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 Summary of the Major Research Project 
Section A 
This is a literature review of patient empowerment in children and young people (CYP) with 
cystic fibrosis (CF), using a meta-synthesis of 17 qualitative studies. Thematic synthesis 
identified analytic themes: ‘relational support’, ‘information and understanding’, ‘feeling 
heard and respected’, ‘mastery and competence’, appeared to facilitate empowerment; 
‘prejudice and assumptions’ was identified as a potential barrier. ‘Navigating being different’ 
appeared to both influence and be influenced by empowerment. Findings provide an initial 
understanding of factors influencing empowerment in CYP with CF. Potential clinical and 
research implications are considered. 
Section B 
This is an empirical paper presenting a grounded theory study that aims to develop a 
preliminary theory of empowerment in CYP with CF. Seven young people with CF, five 
parents and four professionals were interviewed. The emerging model suggests that ‘thriving 
alongside CF’ may be supported by interactions between ‘having a team’ and ‘taking charge 
and having a voice’, leading to ‘being able to just be a child/getting on with life’. ‘Concealing 
self’ may get in the way of ‘thriving alongside CF’. These processes occur within wider 
medical and developmental contexts. Study limitations, clinical and research implications are 
discussed. 
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Part A 
Abstract 
Background 
Health services are increasingly recognising the importance of patient empowerment. Little is 
known about empowerment in children and young people (CYP) with long term conditions. 
Recent medical advances have dramatically increased life expectancy of CYP with cystic 
fibrosis (CF). Patient empowerment may be particularly important in CF due to high 
treatment burden and limited peer support opportunities. 
Aim 
To conduct a meta-synthesis of qualitative literature pertaining to empowerment in CYP with 
CF.  
Method 
A systematic search of PsycInfo, Medline, CINAHL and ASSIA databases was conducted. 
Identified studies were critically appraised and data analysed using thematic synthesis. 
Results 
Seventeen studies met inclusion criteria, though none explicitly explored empowerment. 
Thematic synthesis identified six analytic themes: relational support, information and 
understanding, feeling heard and respected, and mastery and competence, appeared to 
facilitate empowerment; prejudices and assumptions was identified as a potential barrier. 
Navigating being different appeared to both influence and be influenced by empowerment. 
Conclusion 
Findings provide an initial understanding of factors influencing empowerment in CYP with 
CF. Potential clinical implications were suggested and the need for further research 
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highlighted, particularly relating to developmental influences and factors unique to CF which 
are not adequately addressed in existing patient empowerment models. 
Key words: Cystic Fibrosis, Empowerment, Adolescents, Children 
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Introduction 
Empowerment 
The concept of empowerment has been used in a wide range of contexts, including 
community work, education, health and social care (Rowlands, 1995). Rappaport (1984) 
defined empowerment broadly as “a mechanism by which people, organizations, and 
communities gain mastery over their affairs” (p.3). In relation to health, the concept has long 
been applied to health promotion approaches and, more recently as a strategy for the 
management of long term conditions (LTCs), primarily amongst adult patients (Cerezo, Juvé-
Udina, & Delgado-Hito, 2016). However, ‘patient empowerment’ has proved particularly 
difficult to define, and has been found to overlap with numerous other concepts including 
self-efficacy, self-determination, self-management and autonomy (e.g. Bravo et al., 2015) 
 
Most literature on patient empowerment has been written from a nursing perspective (e.g. 
Coyne, 2006; Gibson, 1991), whilst psychological theories of empowerment come largely 
from community psychology, e.g. Rappaport (1984) and Zimmerman (1995). The current 
review will use the conceptual definition of patient empowerment employed in the Jørgensen 
et al. (2018) study which explored facilitators of empowerment in the context of adults who 
had undergone cancer treatment. This definition was based on Rappaport (1984) and 
Zimmerman's (1995) work, defining the state of empowerment (a sense of having mastery or 
being in control) and the process of empowerment (whereby people build motivation, skills 
and knowledge in order to take ownership of their situation).   
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Patient empowerment is increasingly being recognised both nationally and internationally as 
a mechanism for improving health outcomes, health system performance and satisfaction 
with health care (World Health Organization Regional Office for Europe, 2013). Previous 
research involving adult patients with a range of LTCs has found that empowering patients 
increases adherence and promotes positive health outcomes (Prigge, Dietz, Homburg, Hoyer, 
& Burton, 2015; Yeh, Wu, & Tung, 2018). A number of previous qualitative reviews have 
explored patient empowerment in the context of specific patient groups, e.g. adults in 
remission from cancer (Jørgensen et al., 2018) or adults in the advanced stages of a life-
limiting illness (Wakefield et al., 2018). Other previous qualitative reviews took a particular 
focus, e.g. the impact of technology on empowerment across adult patients with a range of 
LTCs (Calvillo, Román, & Roa, 2015). 
 
Facilitators of patient empowerment in adults have been found to include access to 
information, feeling respected, having an active role, good communication between patients 
and healthcare professionals, support from being in a group and religion/spirituality (Bravo et 
al., 2015; Jørgensen et al., 2018). Many previous reviews focusing on patient empowerment 
have explicitly excluded children and young people (CYP) (e.g. Bravo et al., 2015). 
There is now growing interest in patient empowerment in adolescents and a scale of 
empowerment has recently been developed for use with CYP with LTCs (Acuña Mora et al., 
2018). There is some evidence to suggest a correlation between empowerment and quality of 
life in CYP with LTCs including diabetes and congenital heart disease (Acuña Mora et al., 
2019). However, this was based on models of patient empowerment developed from research 
with adult patients with a range of LTCs and may not reflect the empowerment experiences 
of CYP growing up with LTCs. 
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To the author’s knowledge there have been no previous systematic reviews of empowerment 
in CYP with LTCs. Empowering CYP with LTCs is essential for future engagement and has 
the potential to impact significantly on long term health outcomes. This is particularly 
important in cystic fibrosis (CF) due to the significant treatment burden and the inability of 
people with CF to meet in person to access peer support due to risks of cross-infection 
(Cystic Fibrosis Trust, 2019). 
 
Cystic Fibrosis 
CF is a multisystemic condition with a high treatment burden; daily therapies typically 
include chest physiotherapy, nebulised medication, pancreatic enzymes, nutritional 
supplements and antibiotics (Malone et al., 2017). CF is the most common life-limiting 
genetic condition affecting white populations (Williams & Barker, 2010). Approximately one 
in every 2,500 babies born in the UK will have CF (Cystic Fibrosis Trust, 2019). Fifty years 
ago it would be unlikely for a child with CF to live to their 10th birthday (Coulthard, 2018). 
With universal screening, earlier diagnosis, new understandings and treatments there has 
been a dramatic increase in life expectancy with over half of people with CF living beyond 
the age of 47 (Cystic Fibrosis Trust, 2019). 
 
Although people with CF are now living longer they are often affected by significant 
morbidity (Coulthard, 2018). Improved survival means that people with CF and their families 
have to cope with the demands of living with the condition longer, and managing 
increasingly complex regimens (Sawicki et al., 2013).  While there is variation in disease 
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severity and progression, many individuals require frequent inpatient treatment alongside 
complex home treatment regimens throughout their lives. 
 
Although there is some disagreement within the literature, it appears that the additional 
psychosocial challenges associated with having CF increase the risk of experiencing 
psychological distress (Cruz, Marciel, Quittner, & Schechter, 2009). Psychological 
adjustment and health-related behaviours in CYP with CF have been found to be impacted by 
different psychosocial factors at different stages of development (Ernst, Johnson, & Stark, 
2011). It is likely that factors influencing empowerment will also vary according to age and 
developmental stage. 
Developmental perspectives 
 
Patient empowerment may be more complex in CYP due to the roles played by parents in the 
management of LTCs in childhood and the influence of peers (Kirk et al., 2013). There are 
likely to be interactions between CF and all stages of development (Ernst et al., 2011). 
Diagnosis often occurs soon after birth during the initial bonding stage which may impact on 
attachment relationships. During early childhood, issues may arise related to interactions 
between developing self-regulation and CF regimens. For example developing language 
abilities, cognitive development in areas such as understanding causality and experimenting 
with ability to control the environment may lead to battles over mealtimes or completing 
physiotherapy (Ernst et al., 2011). 
 
11 
 
The school years are characterized by increasing cognitive ability and increasing emphasis on 
peer relationships. As cognitive and language skills develop, CYP become more able to 
communicate their own health-related beliefs and expectations. According to Erikson’s 
psychosocial development model (1959), the key conflict for resolution during this stage is 
industry versus inferiority. Through processes such as comparing themselves with peers and 
being recognised by parents and teachers, CYP begin to develop a sense of identity and 
competence. During this stage ‘being different’ from peers can be particularly challenging. 
 
Historically CYP with CF benefited from peer support through residential events. This helped 
to reduce isolation, protected against stigmatisation and increased quality of life through the 
sharing of adaptive coping strategies. In the mid-1990s, the dangers of cross-infection were 
recognised, resulting in strict infection control policies, including guidance that patients 
should not ever meet in person (Ernst et al., 2011). 
 
During adolescence, CYP typically begin to develop a sense of independent identity, spend 
proportionally more time with peers than family, develop romantic relationships and plan for 
the future (Erikson, 1959; Taylor, Gibson, & Franck, 2008). For CYP with CF this period of 
rapid developmental change often coincides with a worsening of CF symptoms such as cough 
and fatigue, increased frequency of pulmonary exacerbations (episodes of intense disease 
activity) and associated increases in treatment burden (Hegarty, MacDonald, Watter, & 
Wilson, 2009). At a time when CYP would otherwise be becoming more independent and 
spending time with friends, deterioration of their health may cause them to become isolated 
and more dependent on family, needing to stay at home or being admitted to hospital (Iles & 
Lowton, 2008). 
12 
 
 
Summary 
 
Much of the literature on patient empowerment has focused on adults with LTCs. There is 
growing interest in CYP patient empowerment (Acuña Mora et al., 2018), though much of 
the existing research has attempted to map understandings of adult patient empowerment onto 
CYP. This is likely to overlook the potential complexities of patient empowerment in CYP 
relating to developmental factors and systemic influences such as parents, teachers and peers. 
Empowerment may be particularly important for CYP with CF due to high treatment burden 
and potential for isolation. 
 
As little research has been conducted in this area and the review sought to develop a broad 
understanding of the complexities of the experiences of CYP with CF in relation to 
empowerment, only qualitive  studies were included (Flemming, José Closs, Hughes, & 
Bennett, 2016). 
 
Aim 
To conduct a meta-synthesis of the qualitative literature that elucidates experiences of CYP 
with CF in relation to empowerment facilitators and barriers. 
Method 
This review was guided by the ENTREQ (enhancing transparency in reporting the synthesis 
of qualitative research) framework (Tong, Flemming, McInnes, Oliver, & Craig, 2012), 
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which includes a checklist designed to improve the quality of reviews using meta-synthesis in 
the context of health research.  
 
A review protocol was developed prospectively and registered on PROSPERO, an 
international register of systematic reviews, used by researchers conducting reviews in the 
field of health. Prospective registration of systematic reviews helps avoid duplication, 
increases transparency and encourages methodological rigor (Stewart, Moher, & Shekelle, 
2012). 
 
Meta-synthesis refers to systematic approaches to reviewing qualitative research. Several 
methods exist for conducting meta-synthesis (Dixon-Woods et al., 2006). Thematic synthesis 
(Thomas & Harden, 2008) was selected for this review as it was developed to address 
questions about people’s perspectives and experiences, and consists of a clear set of steps: 
• Preparatory phase – searching the literature; screening and assessing the quality of 
the papers; extracting data from the selected literature.  
• Thematic synthesis: a) initial coding of text; b) developing descriptive categories; 
c) generating analytical themes 
In order to promote rigour, a bracketing interview was undertaken to consider how the 
researcher’s prior experiences, biases and assumptions may impact on the thematic synthesis 
and the NVivo 12 software package was used to maintain a clear audit trail of the 
development of descriptive and analytical themes. 
 
The rest of this review will use the headings suggested by Thomas and Harden (2008). 
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Preparing for thematic synthesis 
 
Search strategy 
The search strategy was guided by the SPIDER (Sample, Phenomenon of Interest, Design, 
Evaluation, Research type) framework – a tool developed to facilitate rigour in reviews of 
qualitative and mixed method research (Cooke, Smith, & Booth, 2012). Two domains were 
identified to combine within the search strategy: 
• Sample – children and young people with cystic fibrosis 
• Phenomenon of Interest - patient empowerment  
 
In line with Cochrane guidance (Malone et al., 2017), terms for ‘children and young people 
0-19 years’ were not used to limit the search, in order to maximise relevant results. Similarly, 
a decision was made not to include terms for ‘qualitative research’ as there are numerous 
qualitative methods that may be described by authors in a multitude of ways (Barroso et al., 
2003). Search terms (Table 1) were generated from existing research and theoretical literature 
relating to patient empowerment (Acuña Mora et al., 2019; Bravo et al., 2015; Jørgensen et 
al., 2018; Wakefield et al., 2018). Various combinations of concept heading and search terms 
were trialled before settling on a broad search strategy. PsycInfo, Medline, CINAHL and 
ASSIA databases were selected for their relevance to the field and searched from inception to 
March 2019. 
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Table 1  
 
Search terms 
Search Terms 
PsycInfo 
Ovid 
Medline CINAHL ASSIA 
Attitude to Health/  X   
CF    X 
CF Key Words X X   
CF Key Words in abstract   X X 
CF Mesh terms X X   
collaborative care   X X 
collaborative care.mp. X X   
confidence   X  
confidence.mp. X    
control.mp. X    
cystic fibrosis   X X 
cystic fibrosis.mp. X    
Cystic Fibrosis/px [Psychology]  X   
Decision Making/  X   
Delivery of Health Care, Integrated/  X   
empowerment   X  
Empowerment Key Words X X   
Empowerment Key Words in abstract   X X 
Empowerment Mesh terms X X   
Empowerment MM   X  
exp "Internal External Locus of 
Control"/ X    
exp Autonomy/ X    
exp Client Attitudes/ X    
exp Client Education/ X    
exp Client Participation/ X    
exp Cystic Fibrosis/ X    
exp Empowerment/ X    
exp Health Literacy/ X    
exp Interpersonal Control/ X    
exp Self-Care Skills/ X    
exp SELF-CONFIDENCE/ X    
exp Self-Determination/ X    
exp Self-Efficacy/ X    
exp Self-Management/ X    
integrated care   X X 
integrated care.mp. X X   
Internal-External Control/  X   
mastery   X X 
mastery.mp. X X   
mucoviscidosis   X X 
mucoviscidosis.mp. X    
patient activation   X X 
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patient activation.mp. X X   
patient autonomy   X X 
patient autonomy.mp. X X   
patient centered care   X X 
patient centered care.mp. X X   
patient centred care   X  
patient education   X X 
Patient Education as Topic/  X   
patient education.mp. X X   
patient empowerment   X X 
patient empowerment.mp. X X   
patient engagement   X X 
patient engagement.mp. X X   
patient focused care   X X 
patient focused care.mp. X X   
patient involvement   X X 
patient involvement.mp. X X   
patient participation    X 
patient participation.mp X X   
Patient Participation/px [Psychology]  X   
patient preference   X X 
patient preference.mp. X X   
Patient Preference/px [Psychology]  X   
Patient-Centered Care/  X   
perceived control   X X 
perceived control.mp X X   
Personal Autonomy/  X   
Power (Psychology)/  X   
self advocacy   X X 
self advocacy.mp. X X   
self care   X X 
self care.mp. X X   
Self Care/px [Psychology]  X   
Self Concept/  X   
self efficacy   X X 
self efficacy.mp. X X   
Self Efficacy/  X   
self-advocacy   X  
self-care   X  
self-efficacy   X  
shared care   X X 
shared care.mp. X X   
shared decision making   X X 
shared decision making.mp. X X    
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Inclusion criteria 
Studies were included where (a) participants were CYP with CF (i.e. ≤ 18 years) or explicitly 
under the care of paediatric CF services; (b) the participants’ perspectives were explored; (c) 
a qualitative research design was used; and, (d) at least one empowerment indicator was 
described. Based on the conceptual definition of empowerment described above, these 
indicators were: feeling in control, having mastery, being in charge, having influence, having 
agency, or having autonomy. Due to the significant role of family context plays in the lives of 
CYP , studies that reported perspectives of other family members in addition to the 
perspectives CYP with CF were included. 
Screening 
The screening process is shown in Figure 1. Duplicate articles were removed and remaining 
studies screened for relevance of title and abstract. Where there was uncertainty, full texts 
were obtained for further review and reasons for exclusion documented. 
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Figure 1: PRISMA diagram 
 
 
 
 
 
   
 
 
 
  
Records identified through database searching n = 774 
(PsycInfo = 183, Medline = 329, CINAHL = 186, ASSIA =76) 
Additional records 
identified through manual 
searching n = 1 
Total n = 775 
Records after duplicates removed n = 660 
Records screened (title and abstract) n = 660 
Records excluded n = 597 
• Not about the population n = 261 
• Biomed n = 57 
• Review/commentary n = 69 
• Study protocol n = 1 
• Not qualitative n = 141 
• No patient perspective n = 64 
• Unable to access abstract n = 4 
 
Full-text articles assessed for eligibility n = 63 Records excluded n = 44 
• Not paediatric n = 27 
• Not qualitative n = 14 
• No empowerment indicators 
described n = 5 
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Quality assessment 
Assessing quality in qualitative research is complex. Qualitative methods have a range of 
different philosophical underpinnings, and are varied and broad. There is much debate as to 
whether qualitative studies should undergo quality assessment as part of the review process 
(Carroll, Booth, & Lloyd-Jones, 2012). As there are no widely accepted methods for 
excluding qualitative studies from reviews on the basis of quality, Thomas and Harden (2008) 
suggested the solution of sensitivity analysis. In this approach, the possible impact of study 
quality on the reviews’ conclusions are considered after the thematic synthesis by examining 
the relative contribution of each study to final themes and recommendations. 
 
Study quality was assessed using a tool for appraising qualitative research developed by the 
Critical Appraisal Skills Programme [CASP] (Public Health Resource Unit, 2006) and the 
criteria for assessing research conducted with children used by Thomas et al. (2003) 
(Appendices A-B). Whilst numerous quality assessment tools could have been used, the 
CASP checklist was selected because it has a strong methodological focus (Leung, 2015) 
covering clarity and appropriateness of the research question and design, appropriateness of 
the recruitment strategy, data collection and analysis, issues of reflexivity, ethics, levels of 
support and evidence for claims and the overall contribution of the research. Additional 
criteria used by Thomas et al. (2003) were used to supplement the CASP checklist as it was 
felt important to consider quality issues specific to research with CYP.  
Meta-synthesis process 
As detailed below, the meta-synthesis followed the steps outlined by Thomas and Harden 
(2008). 
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Extracting data from the selected articles 
Characteristics of studies meeting the inclusion criteria were entered into a template along 
with the empowerment indicators described by the study. Following the approach of Thomas 
and Harden (2008), all data labelled as ‘results’ or ‘findings’ was extracted digitally and 
imported verbatim into NVivo 12 software for qualitative analysis. 
 
Thematic synthesis 
Coding text and developing descriptive themes 
Data was analysed inductively. Descriptive codes were assigned to sections of text through 
the process of line-by-line coding, resulting in a total of 53 initial codes. Initial descriptive 
codes were then compared and grouped into a hierarchical tree structure. New codes were 
created to capture the meaning of groups of initial codes, resulting in a tree structure with 
several layers of descriptive themes. For example, some of the text that was initially coded as 
‘relationship with health care professionals’ from one study (Nuttall & Nicholes, 1992)  was: 
“I’m happier if I can negotiate and be involved and knowledgeable about my care; I know my 
body best.” This use of line-by-line coding enabled the translation of concepts from one 
study to another (Thomas & Harden, 2008). 
Generating analytical themes 
Whilst the descriptive themes adhered closely to the original findings of included studies, 
generation of analytical themes aimed to move beyond the findings of the primary studies to 
generate new concepts, understandings and hypotheses. As per Thomas and Harden (2008) 
‘going beyond’ the content of the original studies was achieved by using the descriptive 
themes that emerged from the inductive analysis to provide answers to the more abstract 
review question. 
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Facilitators of empowerment, and barriers to empowerment for CYP with CF were inferred 
from the views of CYP and the interpretations provided by researchers in original studies. 
Generation of analytic themes was done independently by the author and discussed in 
supervision and with research peers. Through discussion, more abstract and analytical themes 
began to emerge. Facilitators of empowerment, barriers to empowerment, and implications 
for clinical practice and research were examined again in light of these increasingly analytic 
themes and changes made as necessary. This process was repeated until themes were 
sufficiently abstract to describe and/or explain the initial descriptive themes, inferred 
facilitators and barriers and the clinical and research implications. 
 
Results 
The database search identified 774 papers, of which 16 were relevant for inclusion. An 
additional paper was identified through searching reference sections. Table 2 summarises the 
17 included studies. 
 
This review aimed to include enough information about the original studies to enable the 
reader to understand the context in which the findings were developed. The results section 
will start with an overview of included studies. A methodological critique of the studies will 
then be provided, followed by the thematic synthesis. 
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Table 2 
 
Summary of studies 
Author, 
year, 
country 
Aims Participants Data collection Qualitative 
analysis 
Empowerment 
indicators  described 
(Jørgensen et al., 2018) 
Ayers et 
al. (2011)  
UK 
To understand the 
nature and 
treatment of needle-
related distress in 
children with CF 
14 child-parent dyads. 
Children were 5 males, 9 
females aged 7-17yrs with 
CF. All participants White 
European. Frequency of 
needle procedures ranged 
from 1-6 times a year, no 
other indicators of CF 
severity reported. 
Interviews Thematic 
analysis 
(Boyatzis, 
1998) 
Feeling in control, 
having influence 
Barker et 
al. (2012)  
USA 
To investigate 
perspectives on the 
support adolescents 
received from 
friends / family in 
CF management 
24 adolescents with CF; 
mean age 15.7 years, 50% 
female,17% Hispanic no 
other ethnicity data 
reported, mean FEV1a % 
73.6% ±24.1, 
Interviews Template 
analysis 
(King, 
1999) 
Feeling in control, 
being in charge, 
autonomy 
Christian 
& D'Auria 
(1997)  
USA 
To explore 
adolescents’ 
conceptualisations 
of CF & related life 
events 
20 12-18yr olds with CF; 
12 female, 8 male; 17 
described as white, 3 as 
Native American; CF 
severity: 6 mild, 14 
moderate 
Interviews Grounded 
theory 
(Strauss & 
Corbin, 
1990) 
Feeling in control, 
having influence, 
agency 
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Christofid
es et al. 
(2016) 
Canada 
To explore research 
decision processes, 
particularly in 
children with CF 
who are extensively 
involved in 
research 
19 8-18yr olds with CF (12 
female, 7 male); ethnicity 
& CF severity not reported 
Interviews Thematic 
analysis 
(Braun & 
Clarke, 
2006) 
Feeling in control, 
having influence, being 
in charge,  agency 
Dashiff et 
al. (2013) 
USA 
To describe the 
experience of CF-
related diabetes 
(CFRD), and the 
relationship of 
adolescent disease 
self-management 
with parental 
support. 
10 15-19yr olds (30% 
female, 70% male), 90% 
described as Caucasian 
(non-Hispanic), 10% 
Black, CF severity not 
described. Included parent 
perspective. 
Mixed 
methods: 
Interviews; 
quantitive 
questionnaires 
Qualitative 
description 
(Sandelows
ki, 2000) 
Being in charge, having 
mastery, agency, 
autonomy 
D'Auria et 
al. (1997) 
USA 
To understand the 
middle-childhood 
experience of CF as 
a chronic illness 
20 children aged 6-12yrs 
with CF, 12 males 8 
females, all Caucasian, CF 
severity not reported. 
Interviews Grounded 
theory 
(Strauss & 
Corbin, 
1990) 
Having influence, 
agency 
Durst et 
al. (2001)  
USA 
To understand CF 
patients’ common 
themes and 
emotional 
responses, post 
lung-transplant 
19 adolescent transplant 
recipients with CF. Mean 
age at transplant 15.7 ± 2.7. 
Time from transplant to 
interview 1-58 months. 11 
female, 8 male. 15 
Caucasian, 3 Latino, 1 
African American; no other 
indicators of CF severity 
reported 
Interviews Ethnographi
c study 
design – no 
further 
details of 
data 
analysis 
provided 
Feeling in control 
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Foster et 
al. (2001) 
UK 
To explore the 
impact of CF and 
treatment on 
patients and first-
degree relatives 
8 10-18yr olds with CF (5 
female, 3 male). 8 parents, 
8 siblings. Ethnicity not 
reported. FEV1a 38-114% 
Interviews Grounded 
theory 
(Glaser & 
Strauss, 
1967) 
Being in charge, agency 
or autonomy 
Moola & 
Faulkner 
(2014) 
Canada 
To describe 
attitudes to illness 
and how illness 
narratives affect 
attitudes towards 
physical activity in 
children with CF. 
Part of a broader 
study (Moola et al. 
2011) evaluating a 
physical activity  
counselling 
intervention. 
  
2 adolescents with CF aged 
16 & 17yrs (1 female, 1 
male); ethnicity not 
reported; CF severity: 
moderate FEV1a = 85% 
Multiple 
interviews. Part 
of a wider 
intervention 
study. 
Thematic 
analysis 
(Braun & 
Clarke, 
2006); Case 
study 
analysis 
(Stake, 
2000) 
Feeling in control, 
having mastery, being 
in charge, having 
influence, agency, 
autonomy 
Moola et 
al. (2012) 
Canada 
To explore  
perceptions of 
exercise in young 
people with CF 
14 young people with CF 
aged 11-17yrs (10 female, 
5 male) 13 described as 
Caucasian, 1 as Black, 1 as 
East Indian. CF severity 
not reported. 
Interviews Grounded 
theory 
(Charmaz, 
2003) 
Having mastery, agency 
Nuttall & 
Nicholes 
(1992) 
USA 
To describe 
problems arising in 
adolescents with 
CF related to 
maternal concerns, 
hospital/ home 
care, and healthcare 
20 adolescents with CF; 11 
female, 9 male; mean age 
17.9yrs; 98% Caucasian; 
CF severity described as 
'moderate advanced' 
Interviews Content 
analysis (no 
reference 
provided) 
Feeling in control, 
being in charge, having 
influence, agency or 
autonomy 
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professionals’ role 
in promoting care 
Pizzignacc
o & de 
Lima 
(2006)  
Brazil 
To identify the 
routines of CYP 
with CF and 
situations that can 
affect these routines 
8 7-18yr olds with CF; 
gender, ethnicity, & CF 
severity not reported 
Ethnographic 
design: 
Interviews, 
field diary 
notes & patient 
chart review 
Thematic 
analysis - 
no further 
details of 
data 
analysis 
provided 
Feeling in control,  
being in charge, having 
influence, agency or 
autonomy 
Savage & 
Callery 
(2007) 
Ireland 
To explore children 
and parents’ 
perspectives on 
communication 
between children, 
parents & 
professionals about 
CF diet. 
32 children with CF aged 
6-14yrs (18 female, 14 
male); ethnicity not 
reported; CF severity: 
children in sample ranged 
from below 3rd to above 
97th percentile for height 
& weight. Included parent 
perspective. 
Interviews; 
observations of 
clinical 
consultation 
Discourse 
analysis 
(Potter, 
1997) 
Feeling in control, 
being in charge, having 
influence, agency or 
autonomy 
Sawicki et 
al. (2015) 
USA 
To explore 
facilitators and 
barriers to 
adherence with 
chronic CF 
therapies; 
perspectives of 
adolescents and 
their parents. 
18 adolescents with CF 
aged 16-21yrs (10 female, 
8 male). Ethnicity not 
reported. Mean FEV1a = 
91% (range 38-127%), 
Mean BMI 21.9 (range 
18.7 - 24.6) 
Interviews Thematic 
analysis? - 
no further 
details of 
data 
analysis 
provided 
Feeling in control, 
having mastery, being 
in charge, having 
influence, agency, 
autonomy 
Williams 
et al. 
(2007a) 
UK 
To explore the 
nature and variation 
in roles of family 
members, and how 
responsibility is 
32 children with CF aged 
7-17yrs (18 female, 14 
male); ethnicity not 
reported; CF severity 
reported as: 16 mild FEV1a 
Interviews Framework 
analysis 
(Ritchie & 
Spencer, 
1994) 
Feeling in control, 
having mastery, being 
in charge, having 
influence, agency, 
autonomy 
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transferred from the 
parent/family to the 
child, and what 
factors aid or 
hinder this 
> 70%, 9 moderate 51-
69%, 8 severe 20-50% 
Included parent 
perspective. 
Williams 
et al. 
(2007b) 
UK 
To explore child 
and parent accounts 
of the difficulties of 
adhering to chest 
physio for CF, and 
identify strategies 
used by families to 
overcome these. 
32 children with CF aged 
7-17yrs (18 female, 14 
male); ethnicity not 
reported; CF severity: 15 
mild FEV1a > 70%, 9 
moderate 51-69%, 8 severe 
20-50%. Included parent 
perspective. 
Interviews Framework 
analysis 
(Ritchie & 
Spencer, 
1994) 
Feeling in control, 
having mastery, being 
in charge, having 
influence, agency or 
autonomy 
Williams 
et al. 
(2009) UK 
To describe the 
idea of normality:  
forms, meaning and 
importance. 
32 children with CF aged 
7-17yrs (18 female, 14 
male); ethnicity not 
reported; CF severity: 15 
mild FEV1a > 70%, 9 
moderate 51-69%, 8 severe 
20-50% 
Interviews Framework 
analysis 
(Ritchie & 
Spencer, 
1994) 
Feeling in control, 
having mastery, being 
in charge, having 
influence, agency or 
autonomy 
 
a FEV1 (forced expiratory volume in 1 second) is a measure of CF disease severity. An FEV1 of 100% means that lung function is as would be 
expected for a person of the same age and height who doesn’t have CF. FEV1 ≥ 85% is considered normal; 70-84% indicates mild lung disease, 
41-69% indicates moderate lung disease; ≤ 40% suggests severe lung disease (UK Cystic Fibrosis Registry, 2013). 
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Characteristics of studies and participants 
Studies were published between 1992-2016 in peer-reviewed journals from a range of 
disciplines including medicine, nursing and psychology. Despite a thorough search, not 
limited by date, no studies published outside of the above date range were found to meet 
eligibility criteria. Studies took place in a variety of geographical and cultural contexts 
including USA, Canada, Brazil, UK and Ireland.  
 
A total of 324 CYP were included in the 17 studies. Participants ranged in age from 6-21, and 
were predominantly white, though there were representatives from black and Asian 
communities. Studies included CYP whose CF ranged from mild to severe.  
 
The majority of studies employed purely qualitative methods (n=16), the remainder used 
mixed methods. All studies used interviews as the primary qualitative data collection method. 
A minority additionally used field dairy notes and patient chart review (n=1) or clinic 
observations (n=1). A wide range of data analysis methods were used including: thematic 
analysis (n = 5), grounded theory (n=4), framework analysis (n=3), template analysis (n=1), 
content analysis (n=1), discourse analysis (n=1), qualitative description (n=1) and 
ethnography (n=1). 
 
Focus of studies 
All included studies described at least one empowerment indicator as defined by Jørgensen et 
al. (2018). Within this, studies covered a broad range of topics, including identity, decision-
making, adherence, the role of family and friends, and communication with healthcare 
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professionals.  The majority of studies focused on a specific issue, e.g. needle-related distress, 
CF-related diabetes, or coping post-lung transplant. Other studies explored the experience of 
growing up with CF more broadly. 
 
Quality assessment 
As described above, the quality of studies was assessed using the CASP qualitative 
assessment checklist, supplemented by criteria designed for assessing research conducted 
with CYP. Appendix C provides an overview of key strengths and limitations of all studies. 
An overview of quality assessment ratings is provided in Appendix D. 
 
Aims and design 
All studies provided a clear statement of aims. Whilst specific aims and objectives varied 
between studies, all aimed to provide rich descriptions of complex phenomena and thus 
qualitative research methodology was appropriate. 
 
There was significant variation in the level of detail in which study design was reported. Only 
three studies (Williams et al., 2009; Williams et al., 2007b, 2007a) reported actively 
involving CYP in the design and conduct of the study. Few studies provided a detailed 
rationale for choice of specific qualitative method. 
 
Participants and sampling 
Unlike quantitative research, there is little consensus on what constitutes adequate sample 
size in qualitative studies. Sample size ranged from a small case series involving two 
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participants to large scale qualitive studies involving 32 participants. Studies varied in the 
reporting of demographic variables, though all reported age and gender. 
 
Most studies clearly reported an appropriate recruitment strategy (generally convenience or 
purposive sampling). Most studies acknowledged the role clinicians played in recruitment. 
Few authors reflected on how many and why potential participants choose not to participate. 
 
Ethical considerations 
The majority of studies (n=14) reported obtaining appropriate ethical approvals. All but two 
studies (Durst et al., 2001; Moola & Faulkner, 2014) described procedures for obtaining 
informed consent/assent. Only a minority of studies explicitly referred to confidentiality and 
none reported procedures for responding to any participant distress relating to the research. 
 
Data collection and analysis 
Studies varied in the level of detail reported regarding data collection processes. Twelve 
noted the use of topic guides and gave an overview of topics. The majority of studies reported 
details of audio-recording and transcription. 
 
Reporting of details relating to the process of qualitative analysis varied between studies, 
though most described and clearly referenced specific forms of analysis. Most studies clearly 
evidenced using appropriate methods for ensuring data analysis was grounded in the views of 
children, though few authors made reference to data saturation. 
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Reflexivity 
Researcher sensitivity to the ways in which the researcher and research process shape the 
data, including personal characteristics, prior experiences and assumptions, is referred to as 
reflexivity (Mays & Pope, 2000). This was a weakness across studies, as only three studies 
(Moola et al. 2012; Sawicki et al. 2015; Williams et al. 2009) demonstrated reflexivity. 
Moola et al. (2012) described using bracketing techniques to become cognizant of 
preconceived assumptions, while Sawicki et al. (2015) included some discussion of the 
potential for bias. Williams et al (2009) was the only study to describe external validation. 
 
Validity of study findings 
Although all studies were explicit in reporting findings there was variation in levels of 
evidence provided. Some authors discussed credibility of findings, but none reported 
respondent validation. Approximately two thirds of studies specified that data was analysed 
by more than one researcher; inter-rater reliability was reported where this was consistent 
with the data analysis method (e.g. template or content analysis).  
 
Although not the focus of the current review, approximately half the studies included parent 
perspectives, adding to the validity of findings. Other studies demonstrated triangulation of 
data through use of life event lines (Christian & D’Auria, 1997; D’Auria et al., 1997), 
reviewing patient notes and field notes (Pizzignacco & de Lima, 2006) or clinic observations 
(Savage & Callery, 2007). 
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Williams et al. (2007b) and Williams et al. (2009) added to the validity of findings through 
attention to negative cases (Mays & Pope, 2000). Williams et al. (2009) sought external 
validation through the employment of two researchers not otherwise involved with the study. 
 
Thematic synthesis 
The thematic synthesis resulted in the generation of six analytical themes (highlighted in 
bold). Facilitators of empowerment appeared to include having relational support, having 
information and understanding, feeling heard and respected, and experiencing mastery 
and competence. In contrast the prejudice and assumptions of others could be a barrier to 
empowerment, whilst navigating being different appeared to both influence and be 
influenced by empowerment. 
 
Themes, associated subthemes and the studies contributing to each theme are described in 
Table 4, while representative quotations are shown in Table 5. 
 
In some cases, there was a direct connection between the data and empowerment; for others, 
further synthesis was required. In contrast to quantitative approaches to data synthesis, the 
number of contributing studies is not necessarily representative of the strength of the theme 
(Dixon-Woods et al., 2006).  
 
Themes identified through the review process as appearing to facilitate empowerment will be 
reported first, followed by themes relating to potential barriers to empowerment. Themes 
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relating to processes that both influence and are influenced by empowerment will then be 
described. 
 
 
Table 4 
Table of studies contributing to themes 
Theme Subtheme Contributing studies 
Relational support 
 
 
 
 
Treatment related support 
 
 
 
 
Emotional support 
Ayers, Muller, Mahoney, & Seddon, 
2011; Barker et al., 2012; Dashiff, 
Suzuki-Crumly, Kracke, Britton, & 
Moreland, 2013; Moola & Faulkner, 
2014; Nuttall & Nicholes, 1992; 
Sawicki et al., 2015; Williams et al., 
2009, 2007b; Williams, 
Mukhopadhyay, Dowell, & Coyle, 
2007a 
 
Ayers et al., 2011; Christian & 
D’Auria, 1997; D’Auria et al., 1997; 
Dashiff et al., 2013; Durst et al., 2001; 
Moola & Faulkner, 2014; Moola et 
al., 2012; Nuttall & Nicholes, 1992; 
Sawicki et al., 2015; Williams et al., 
2007a, 2007b; Barker et al., 2012; 
Christofides et al., 2016; Foster et al., 
2001; Pizzignacco & de Lima, 2006; 
Savage & Callery, 2007; Williams et 
al., 2009 
 
Information and 
understanding 
Knowledge about CF 
 
 
 
Christian & D’Auria, 1997; 
Christofides et al., 2016; D’Auria et 
al., 1997; Dashiff et al., 2013; Moola 
& Faulkner, 2014; Moola et al., 2012; 
Nuttall & Nicholes, 1992; 
Pizzignacco & de Lima, 2006; 
Williams et al., 2007b 
 
Ayers et al., 2011; Dashiff et al., 
2013; Durst et al., 2001; Moola & 
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Learning from 
experience 
Faulkner, 2014; Sawicki et al., 2015; 
Williams et al., 2007b 
 
Feeling heard and 
respected 
 Ayers et al., 2011; Nuttall & 
Nicholes, 1992; Savage & Callery, 
2007; Sawicki et al., 2015; Williams 
et al., 2009, 2007a 
Mastery and competence  Christian & D’Auria, 1997; D’Auria 
et al., 1997; Durst et al., 2001; 
Nuttall & Nicholes, 1992; Savage & 
Callery, 2007; Sawicki et al., 2015; 
Williams et al., 2009, 2007b, 2007a 
Prejudice and assumptions 
 
 
 
 
 
Bullying 
 
 
Differential 
treatment 
Barker et al., 2012; Christian & 
D’Auria, 1997; D’Auria et al., 1997; 
Foster et al., 2001; Pizzignacco & de 
Lima, 2006; Williams et al., 2009 
 
Christian & D’Auria, 1997; Durst et 
al., 2001; Foster et al., 2001; Moola 
et al., 2012 
Navigating being different Becoming aware of 
difference 
 
 
 
Deciding if and who 
to tell 
 
 
 
 
Christian & D’Auria, 1997; 
D’Auria, Christian, & Richardson, 
1997; Moola, Faulkner, & 
Schneiderman, 2012; Sawicki, 
Heller, Demars, & Robinson, 2015; 
Williams, Corlett, Dowell, Coyle, & 
Mukhopadhyay, 2009 
 
Barker, Driscoll, Modi, Light, & 
Quittner, 2012; Christian & 
D’Auria, 1997; Christofides, 
Dobson, Solomon, Waters, & 
O’Doherty, 2016; D’Auria et al., 
1997; Pizzignacco & de Lima, 2006; 
Sawicki et al., 2015; Williams et al., 
2009; Williams, Mukhopadhyay, 
Dowell, & Coyle, 2007 
 
Christian & D’Auria, 1997; D’Auria 
et al., 1997; Durst et al., 2001; 
Foster et al., 2001; Moola & 
Faulkner, 2014; Williams et al., 
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Perceived threats to 
‘normality’ 
 
 
 
 
Competing priorities 
 
 
 
 
Positive aspects of 
difference 
2009, 2007; Dashiff, Suzuki-
Crumly, Kracke, Britton, & 
Moreland, 2013 
 
Durst et al., 2001; Moola & 
Faulkner, 2014; Moola et al., 2012; 
Nuttall & Nicholes, 1992; Williams 
et al., 2009, 2007b 
 
 
Christofides et al., 2016; Durst et al., 
2001 
 
 
Table 5 
Representative quotations 
Themes  Subthemes Exemplary quotations 
Relational 
support 
Treatment 
related support 
“[Mom] keeps telling me to do it whether I want to or 
not, she knows that it’s going to help me so it’s pretty 
supportive.” (Barker et al., 2012, p. 500) 
 
Emotional 
support 
“I think it's really helpful if you could talk to 
somebody else that had CF. You know it's like a CF 
person. I think that is one of the most helpful things 
that has helped me, those CF camps that we can't, we 
can't have them anymore ... I learned a lot from 
them.” (Christian & D’Auria, 1997, p. 9). 
 
“She [mum] usually just holds my hand and cuddles 
next to me . . . I know she’s there and it’s just better” 
(Ayers et al., 2011, p. 336) 
 
“Get personally involved; don’t be afraid just because 
we may not be around too long.” (Nuttall & Nicholes, 
1992, p. 206) 
Information 
and 
understanding 
Knowledge 
about CF 
“I didn't take my pills at school because that was 
when I first started, 'cause I was like "Why do you 
take your pills?" And I didn't really know what to say 
to them because I was younger ....” (Christian & 
D’Auria, 1997, p. 6) 
 
“I don’t know very much. I know it’s more or less 
similar to Down’s Syndrome. It’s from the same 
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chromosome, I think it is, but I really don’t know for 
sure” (Pizzignacco & de Lima, 2006, p. 572) 
 
“I think it's really helpful if you could talk to 
somebody else that had CF…those CF camps that we 
can't, we can't have them anymore ... I learned a lot 
from them” (Christian & D’Auria, 1997, p. 9) 
Learning from 
experience 
“I like being healthy. It makes me feel good and I did 
not know before that I would feel this way about being 
healthy. Once I did, I felt good, I felt great, and once 
you do that, you do not want to go back.” (Moola & 
Faulkner, 2014, p. 32) 
Feeling heard 
and respected 
 “I’m happier if I can negotiate and be involved and 
knowledgeable about my care; I know my body best.” 
(Nuttall & Nicholes, 1992, p. 204) 
Mastery and 
competence 
 “I’m competent and responsible; I’ve been caring for 
myself all my life.” (Nuttall & Nicholes, 1992, p. 203) 
 
“I could go to people’s houses and stay over because 
I knew how to do my physio. I didn’t have to come 
home and get my mum to do it for me” (Williams et 
al., 2009, p. 1450) 
Prejudice and 
assumptions 
Bullying “All the kids, you know, saying "ewwr".... On the bus” 
(Christian & D’Auria, 1997, p. 6) 
Differential 
treatment 
“I do not want to be treated differently . . . so what, I 
have CF. One of my cousins, he went easy on me in 
sports and I got really mad.” (Moola et al., 2012, p. 
53) 
 
“...my mom never wants me to leave the house...but I 
did not go through transplant to live my life in a 
bubble” (Durst et al., 2001, p. 30) 
Navigating 
being different 
Becoming aware 
of difference 
“I didn't know what it was, 'cause I didn't even know I 
was sick”  (Christian & D’Auria, 1997, p. 6) 
Deciding if and 
who to tell 
“I'm not going to tell my coach I have it. So he won't 
treat me any different than the other kids.”  (Christian 
& D’Auria, 1997, p. 7) 
Perceived 
threats to 
‘normality’ 
“it’s quite hard when I’ve got friends staying or 
something, it’s like I have to go through to the spare 
room do my breathing stuff , whereas if I didn’t have 
CF I wouldn’t have to, I just hate having to do all the 
stuff I have to do.” (Williams et al., 2007b, p. 1100) 
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Competing 
priorities 
“I know that I should do it (activity)—it should be 
higher on the priority list. The more important things 
for me are like work and school” (Moola et al., 2012, 
p. 54) 
 
“...my mom never wants me to leave the house...but I 
did not go through transplant to live my life in a 
bubble” (Durst et al., 2001, p. 30) 
 
Positive aspects 
of difference 
CYP who had undergone lung transplant spoke of 
their surgical scars as representing ‘strength’, 
‘survival’ and a ‘signature point in my life’ (Durst et 
al., 2001, p. 30). 
 
  
Relational support 
Across studies CYP described support from others including family, friends and professionals 
as promoting positive coping with the demands of CF and CF treatment, and enabling 
participation in activities that were important to them. Relational support took a variety of 
forms which can be broadly divided into tangible support associated with treatment regimens 
and more general emotional support. 
Treatment-related support 
In the majority of studies, CYP of all ages implicitly or explicitly referred to the role of 
parents in providing treatment-related support (Barker et al., 2012; Dashiff et al., 2013; 
Moola & Faulkner, 2014; Nuttall & Nicholes, 1992; Sawicki et al., 2015; Williams et al., 
2009). This took a number of forms, including practical support such as undertaking 
physiotherapy with or for CYP, preparing medications, arranging medical appointments, and 
providing treatment reminders and encouragement. In one study (Barker et al., 2012) CYP 
reported that parents sometimes let them ‘slack off’ their treatments and reported this lack of 
monitoring as unsupportive.  
 
In several studies CYP also spoke of the role that friends played in providing treatment-
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related support (Barker et al., 2012; Christian & D’Auria, 1997; D’Auria et al., 1997). 
 
 
Many CYP described the high treatment burden associated with CF and made links between 
receiving support with treatment and being able to do the things that were important to them, 
e.g. spending time with friends or participating in sport. In one study, CYP identified 
treatment-related behaviours such as nagging as annoying or unwanted, but were reluctant to 
describe family members or friends as being ‘unsupportive’ when they engaged in these 
behaviours (Barker et al., 2012). 
 
Where studies included a focus on relationships with health care professionals, the 
importance of consistency and trust was repeatedly articulated (Ayers et al., 2011; Nuttall & 
Nicholes, 1992; Sawicki et al., 2015; B. Williams et al., 2007b, 2007a) 
 
Emotional support 
The importance of emotional support was highlighted by a number of studies across a range 
of contexts. CYP in Ayers et al. (2011) spoke of the role of parents in providing emotional 
support during distressing procedures. In other studies (e.g. Dashiff et al., 2013; Moola et al., 
2012), CYP referred to emotional support more generally, e.g. the role of family members 
‘being there and listening’ (Dashiff et al., 2013).  
 
Participants in several studies noted that alongside practical treatment related support, health 
care professionals often provided essential emotional support (Ayers et al., 2011; Nuttall & 
Nicholes, 1992; Sawicki et al., 2015; Williams et al., 2007a, 2007b).  CYP in several studies 
described the importance of feeling comfortable talking with their CF team about general life 
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concerns. CYP in these studies reported that their medical teams were able to understand 
what their lives were like and empathise with the difficulties of adhering to complex 
treatment regimens (Sawicki et al., 2015; Williams et al., 2007b). A subgroup of CYP in 
Nuttall and Nicholes (1992), expressed wanting professionals to be more emotionally 
involved. 
 
In the Christian and D’Auria (1997) and D’Auria et al. (1997) studies, emotional support 
provided by ‘good friends’ was found to offer protection from the effects of bullying and 
difficulties associated with trying to keep CF a secret, such as feeling unable to take 
medication at school. This was the case both for younger children Christian and D’Auria, 
(1997) and older children (D’Auria et al., 1997). 
 
Interestingly, in the only study to include transplant recipients, CYP reported improved 
interactions with class mates and an improved sense of belonging, post-transplant (Durst et 
al., 2001). It was unclear how participants in this study experienced emotional support from 
friends prior to transplant and during initial recovery. 
 
In several studies (Christian & D’Auria, 1997; Moola & Faulkner, 2014), participants 
referred to support from other CYP with CF. Prior to the mid-1990s, CYP were encouraged 
to socialise through organised events, e.g. summer camps. It became apparent that this 
practice was potentially dangerous due to infection risks, and as a result, strict infection 
control guidelines were introduced in order to prevent face-to-face contact between CYP with 
CF. These studies alluded to the impact of infection control guidelines, which appeared to 
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have been implemented differently between studies, reflecting differing geographical 
contexts and years of study publication. 
 
Information and understanding 
In many studies, CYP described the impact of the amount of information to which they had 
access. Having information and understanding appeared to facilitate empowerment by 
influencing how CYP made sense of their experiences, and how confident they felt in making 
decisions and explaining CF to others. Information appeared to come both from external 
sources (e.g. clinic consultations), and CYP’s own experiences (e.g. learning from the 
consequences of medication non-adherence). 
Knowledge about CF 
Levels of CF knowledge appeared to vary both between and within studies. In several studies, 
CYP with CF and their peers were found to have difficulty understanding the meaning of CF 
and how the label could account for their differences (Christian & D’Auria, 1997; Moola & 
Faulkner, 2014; Pizzignacco & de Lima, 2006).  
CYP in a few studies described awareness of not having the knowledge and skills to feel 
confident in telling their peers about CF (Christian & D’Auria, 1997; D’Auria et al., 1997; 
Pizzignacco & de Lima, 2006). Some CYP reported the experience of being diagnosed with 
complications of CF such as CF-related diabetes (CFRD) as “shocking,” “bad,” “hard,” 
“terrible,” “depressing,” and “agitating”, attributing much of the distress to not understanding 
the meaning and implications of the news (Dashiff et al., 2013). A lack of information and 
understanding about CF limited participation, with some CYP avoiding activities because 
they were unsure what they could do safely or what they might need to do differently 
(Christian & D’Auria, 1997). Some authors interpreted this as a consequence of professionals 
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overestimating the scientific knowledge of CYP and their families (Pizzignacco & de Lima, 
2006). 
 
In one study CYP reported gaining information through participation in research 
(Christofides et al., 2016). In other studies CYP described meeting other children with CF at 
camp gave them a broader perspective of CF and potential implications for their future lives 
(Christian & D’Auria, 1997; Moola & Faulkner, 2014). Nuttall and Nichole's study (1992) 
described CYP wanting more information about CF’s potential impact on areas such as 
careers and fertility to enable them to plan ahead.  
Learning from experience 
Many CYP described learning from experience as a process (Moola & Faulkner, 2014). CYP 
in a number of studies commented on learning from experiencing the consequences of not 
following treatment plans, with subsequent increased adherence (Sawicki et al., 2015; 
Williams et al., 2007b). Some described the development of CF-related comorbidities such as 
CFRD acting as a ‘wake-up call’ (Dashiff et al., 2013). Other CYP commented that skipping 
physio or medication once or twice did not seem to have an impact on their health (Sawicki et 
al., 2015; Williams et al., 2007b). CYP in one study Durst et al. (2001) seemed to take a 
particularly proactive approach to the unpredictable nature of transplant, possibly due to their 
past experiences. 
 
Feeling heard and respected 
The importance of being heard and respected, particularly in the hospital setting, was 
articulated across a number of studies by participants of all ages (Ayers et al., 2011; Nuttall & 
Nicholes, 1992; Savage & Callery, 2007; Sawicki et al., 2015; Williams et al., 2009). This 
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was true both for studies focusing on specific issues such as needle-related distress and for 
studies exploring experiences of growing up with CF more generally.  
 
Many CYP commented on the distress caused when they perceived their voice was not being 
heard (Nuttall & Nicholes, 1992). They suggested patient care could be improved through 
increased patient input in care planning (Nuttall & Nicholes, 1992), and believed that they 
should be the principal person consulted on matters such as diet (Savage & Callery, 2007).  
 
For many older participants it was important to be treated as an adult, seeing the doctor alone 
or the doctor addressing them rather than their parents; having their social life, roles and 
commitments accommodated were important indicators of this (Sawicki et al., 2015; 
Williams et al., 2007a) 
 
 
Mastery and competence  
In many studies CYP made references to the importance of experiencing mastery and being 
perceived by others as competent. This was the case both in relation to CF care and typical 
activities of childhood, e.g. performance in sports.  
 
Some CYP described feeling competent in managing CF as becoming easier over time; others 
spoke of becoming used to it as ‘all I’ve ever known’ (Dashiff et al., 2013). Feeling confident 
and competent in managing CF regimens appeared to increase independence, enabling CYP 
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to adopt more ‘normal’ roles and participate in social activities such as going on trips 
(Williams et al., 2009, 2007a).  
 
CYP in Nuttall and Nicholes (1992) commented on the importance of being recognised as 
competent in self-management of CF. Some CYP said having their parents ‘on them’ all the 
time regarding CF treatment had a negative impact on their behaviour and relationships; 
when their parents stepped back and gave them responsibility for their own care they did 
better (Sawicki et al., 2015). Similarly, in their study of clinic consultations, Savage and 
Callery (2007) found that CYP felt more competent when professionals used a 
communication style that encouraged participation rather than telling them what to do, e.g. 
asking CYP to advise as to which physiotherapy technique they found most helpful. In 
several studies CYP referred to how increasing independence as they grew older allowed 
more autonomy in CF management and made it easier for to appear ‘normal’ to others 
(Williams et al., 2009, 2007b). 
 
CYP in a number of studies commented on enjoyment of physical activities (Moola & 
Faulkner, 2014; Moola et al., 2012; Williams et al., 2009, 2007b). The comments of some 
CYP suggested that these activities provided memorable mastery experiences which resulted 
in an enduring sense of competence and achievement (Moola et al., 2012). In several studies, 
CYP emphasized that CF didn’t stop them from achieving goals and aspirations (Williams et 
al., 2009, 2007b, 2007a). For many of the CYP in these studies this appeared to relate to the 
pursuit of normality and ensuring that personal, hopes, values and aspirations were not 
disrupted by CF. In contrast, participants in the only study to focus on the experiencs of CYP 
who had undergone transplant, described how post-transplant they were now able to do 
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ordinary tasks such as walking without breathlessness, housework, and socialising (Durst et 
al., 2001). 
 
Prejudice and assumptions 
In many studies, CYP described the negative impact of other people’s responses to 
differences associated with CF. Both explicit teasing or bullying and well-intentioned 
differential treatment appeared in some cases to act as barriers to empowerment.  
Bullying 
In a number of studies CYP spoke of attracting negative attention from peers. This was often 
described as one of the most stressful aspects of growing up with CF, with some CYP 
becoming anxious as they anticipated the potential reactions of their peers (D’Auria et al., 
1997). CYP described peers highlighting and mocking CF-related differences and treating 
them with suspicion (Barker et al., 2012; Christian & D’Auria, 1997; D’Auria et al., 1997; 
Foster et al., 2001; Pizzignacco & de Lima, 2006; Williams et al., 2009). For some this 
included being labelled as ‘druggies’ or ‘contagious’, and bullies encouraging other children 
to stay away (Christian & D’Auria, 1997; D’Auria et al., 1997; Foster et al., 2001).  
 
Perceived differential treatment 
CYP in several studies reported being treated differently by others because of CF. These 
perceptions of differential treatment included experiencing teachers and coaches using 
unequal standards to evaluate performance (Christian & D’Auria, 1997), healthy peers being 
less competitive (Moola et al., 2012) and parents disciplining healthy siblings more harshly  
(Foster et al., 2001). CYP in the Durst et al. (2001) study described continuing to feel 
overprotected, post-transplant. Across a number of studies, CYP expressed strong preferences 
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for adults treating them like any other child, and described feeling frustrated, patronized or 
guilty when they perceived differential treatment. 
 
Navigating being different 
CYP’s experiences of navigating differences associated with having CF appeared to influence 
and be influenced by empowerment. 
Becoming aware of difference 
CYP in a number of studies described the process of becoming aware of having CF and of the 
ways that this made them different from other children.  For many children becoming aware 
of ‘being different’ occurred between 6-8 years (Christian & D’Auria, 1997) and was often 
reported as being a surprise (Christian & D’Auria, 1997; D’Auria et al., 1997). Younger 
children in contrast did not reveal any major struggles to mask differences associated with 
having CF such as taking medication (Williams et al., 2009). Whereas older participants 
made reference to issues of difference, sameness, and acceptance, and were found to use 
language that emphasised non-difference (Moola et al., 2012; Sawicki et al., 2015; Williams 
et al., 2009) 
Deciding if and who to tell 
CYP in approximately half the studies mentioned deciding if and who to tell that they had 
CF. Telling others about the CF diagnosis appeared to threaten a normal developmental need 
to gain social approval and develop friendships (Christian & D’Auria, 1997; D’Auria et al., 
1997; Williams et al., 2007b). Many participants described ambivalence about disclosing CF, 
e.g. wanting to tell but fearing that this could jeopardize their potential to have romantic 
relationships (Christian & D’Auria, 1997).  
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Some CYP reported that by not telling teachers and coaches about CF, they could be viewed 
as equally competent in group activities (Christian & D’Auria, 1997). For others, there 
seemed to be a more general reluctance to talk about CF (Christofides et al., 2016).  
Perceived threats to ‘normality’ 
The ‘CF cough’, taking medications and physical limitations were reported by CYP in a 
number of studies as the aspects of CF that most highlighted difference from peers (Christian 
& D’Auria, 1997; D’Auria et al., 1997; Williams et al., 2009). Williams et al. (2007b) found 
that physiotherapy threatened CYP’s sense of ‘non-difference’ in three ways: time taken from 
activities that maintain ‘non-different’ identity; non-participation in typical childhood 
activities; and physiotherapy elements perceived as ‘embarrassing’ and ‘disgusting’ e.g. 
spitting. 
 
Sawicki et al. (2015) grouped comments from CYP under ‘privacy concerns’: wanting to be 
‘normal’, not wanting to be different or disabled, self-consciousness about taking medications 
at school, and not wanting to take CF-related equipment outside the home. Similarly, 
participants in Williams et al. (2007a) described being embarrassed undertaking 
physiotherapy away from home and that joining their peers in typical childhood activities 
such as sleepovers “wasn’t worth the hassle”. Interestingly, CYP expressed a sense of 
belonging and improved interactions with peers post-transplant (Durst et al., 2001).  
Competing priorities 
The impact of having limited time and a high treatment burden was described by CYP across 
studies and age groups. CYP in several studies described the challenge of balancing 
competing priorities within the context of a life-limiting condition (Moola et al., 2012; 
Nuttall & Nicholes, 1992). Many CYP understood that their life expectancy was shorter than 
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that of their peers and questioned whether they would ever attain important developmental 
milestones (Moola et al., 2012). Some older participants in described CF as getting in the way 
of their goals and career aspirations (Williams et al., 2009). CYP in Durst et al. (2001) 
reflected on balancing the risks of infection and transplant rejection against ‘trying to have a 
normal life’, suggesting this continues to be the case, post-transplant. 
 
CYP of all ages reported a sense of inequality and unfairness due to the way that 
physiotherapy restricted their lives compared to their peers (Williams et al., 2007b). Younger 
children who were receiving percussive physiotherapy from their parents expressed a sense of 
loss at not being able to stay overnight with friends or go on school trips as they needed 
parental help with physiotherapy. Older CYP spoke of not being able to stay out as late as 
friends due to physiotherapy (Williams et al., 2009, 2007b). 
 
Although CYP were aware of the benefits of physical activity, for some CF symptoms meant 
that even simple everyday activities were exhausting (Moola et al., 2012). In the only study to 
include CYP’s reflections on an intervention, one participant in Moola and Faulkner's (2014) 
case series reported feeling less limited by CF and more able to consider attending college 
following an intervention involving physical activity and counselling. 
 
Positive aspects of difference 
CYP in several studies noted positive aspects of difference associated with having CF. CYP 
who had undergone lung transplant spoke of their surgical scars as representing ‘strength’, 
‘survival’ and a ‘signature point in my life’ (Durst et al., 2001). 
  
47 
 
 
In Christofides et al.'s  (2016) study of decision-making, some CYP described enjoying 
participating in research, acknowledging opportunities they would not otherwise have had, 
identifying as professional research participants or attributing an interest in science to this 
experience.  
 
Discussion 
To the author’s knowledge, this is the first attempt to synthesise existing qualitative literature 
relating to empowerment in CYP with CF. This review screened 660 journal articles were 
screened and 17 qualitative articles relating to empowerment in CYP with CF were selected. 
Despite a thorough systematic search, no articles explicitly exploring empowerment were 
identified. However, descriptions of empowerment indicators were found in studies covering 
a wide range of topics including identity, decision-making, adherence, interpersonal support 
and communication. 
 
Studies varied in quality. Lack of involvement of CYP in the design and conduct of the 
research and lack of researcher reflexivity were key weaknesses across studies. Whereas 
Thomas and Harden (2008) found that studies of higher methodological quality contributed 
more to their themes, the current study did not find this association. This reflects the findings 
of Jorgensen et al. (2018), study of facilitators of empowerment in adult patients, a finding 
the authors attributed to the inclusion of studies that did not have a specific focus on 
empowerment. Whilst in line with guidance on meta-synthesis, the number of contributing 
studies did not determine the weight of themes, themes that consisted of only a small number 
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of poorer quality studies need to be treated with more caution than more robust themes (e.g. 
‘positive aspects of difference’ versus ‘feeling heard and respected’). 
 
The key facilitators of empowerment in CYP with CF deduced from this review were having 
relational support, having information and understanding, feeling heard and respected, 
and experiencing mastery and competence. Barriers to empowerment emerging from the 
review reflected the opposite of the above-mentioned facilitators, e.g. prejudice and 
assumptions involving bullying or differential treatment could be considered the opposite of 
feeling heard and respected.  
 
This review identified the theme of navigating being different that both influences and is 
influenced by empowerment. Existing theory reflects this dynamic relationship. CYP’s 
identity and sense of mastery and competence develop through comparison with and 
feedback from peers and adults (Erikson, 1959). For CYP with CF, comparison with peers 
may highlight their CF-related differences (coughing, taking medications, fatigue and school 
absences) (Ernst et al., 2011). 
 
There were resonances between emerging themes and empowerment theories developed 
within the context of community psychology (Zimmerman, 1995). For example, having 
information and understanding could be thought of as part of an empowering process (a 
mechanism that increases opportunities for individuals to influence decisions that affect their 
lives and move closer to their goals). Similarly, experiencing mastery and competence 
could be considered an empowered outcome. 
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Many of the emerging themes map on to Bravo et al’s (2015) theory of patient empowerment 
which was developed from research with adults with a range of LTCs. This highlighted the 
importance of ‘feeling respected’, experiencing ‘self-efficacy’ and having access to 
‘knowledge’.  
 
There were also similarities between the current review’s findings and those of previous 
reviews involving studies of adult patients. For example, in a review focusing on facilitators 
of patient empowerment in cancer patients during follow-up, Jørgensen et al. (2018) 
identified themes including ‘knowledge is power’ and ‘communication and interaction 
between patients and health care professionals’. Similarly, in a study of empowerment in 
adults in the advanced stages of life-limiting illness, Wakefield et al. (2018) identified themes 
including ‘personalised knowledge in theory and practice’ and ‘negotiating personal and 
healthcare relationships.’ 
 
Key differences between this review and previous work are that the themes identified in this 
review included a greater emphasis on support from parents and healthy peers; less emphasis 
on support from patient groups; and greater significance of themes related to identity and 
difference. The lives of CYP with or without LTCs are highly influenced by their adult 
caregivers. The findings of the current review suggest that empowerment in CYP with CF 
may be associated with attachment relationships. For example CYP who are able to reliably 
depend on parents and other adults including health care professionals and teachers for 
acceptance, support and information may be more empowered than those with a tendency 
towards more anxious-avoidant relationship patterns who may attempt to be entirely self-
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sufficient or those with an anxious-ambivalent relationship patterns who may struggle to 
separate from caregivers and thus have fewer opportunities to experience mastery and 
competence.  
 
Strengths and limitations 
Developing the search strategy was a challenge as the concept of patient empowerment 
overlaps with other concepts such as self-efficacy, and can be understood and defined in 
many different ways (Bravo et al., 2015). Use of the conceptual definition employed in the 
Jørgensen et al. (2018) study, afforded a relatively clear and comprehensive definition of 
empowerment to guide the search. However, whilst in some ways a strength, this definition 
of empowerment was theoretically based rather than derived from the experiences of patients 
and so could also be seen as a limitation. As noted by Jørgensen et al. (2018) employing a 
theoretically driven definition as the basis for the review may to some extent resulted in the 
review not being able to answer how the patients themselves experienced empowerment. 
Nonetheless, it was considered important to use a single definition of patient empowerment to 
enable a rigorous systematic search and synthesis of identified literature. 
 
The number of participants included was moderate. Quality of included studies was variable 
and sometimes difficult to assess due to the way studies were reported. Most studies were 
conducted in developed countries, and non–English language articles were excluded, 
therefore the transferability of the findings is uncertain. 
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Strengths of this review include the novel review of empowerment in CYP with CF, and that 
emergent themes were represented across the included studies, supporting the validity of the 
findings. 
 
Clinical implications 
The findings of this review highlight the importance of CYP having accessible information, 
feeling heard and respected, and experiencing mastery (including in relation to CF self-
management) in promoting patient empowerment.  
 
It may therefore be useful for clinicians to continuously review with CYP’s understanding of 
CF and to build a library of accessible resources. It may also be useful for service evaluations 
to be conducted, for example, using Likert scales to ascertain the extent to which CYP felt 
heard and respected (etc).  
 
Issues related to CF and other LTCs could be incorporated into the Personal, Social, Health 
and Economic (PSHE) Education curriculum, potentially with involvement of clinicians. 
Clinicians might also work with educators to promote acceptance of difference, find ways of 
managing perceived differential treatment and to support CYP in making choices around 
managing difference, e.g.  by enabling CYP to take medication in private if they wish to.  
 
Strategies that may enhance both feeling heard and respected and mastery and competence 
include development of CYP expert patient groups or patient educator programmes that could 
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teach medical students CF-related history and examination, or be involved in service 
development and in creating CYP-friendly resources. 
 
To support CYP in coming to terms with difference through interventions such as Acceptance 
and Commitment Therapy (ACT) may be beneficial. The decisions CYP have to make in 
balancing CF-treatment choices with day to day social and academic activities of childhood 
are complex, and there may be a role for motivational interviewing or ACT values-based 
work.  
 
Research implications 
None of the studies looked explicitly at empowerment in children with CF. Further 
qualitative research is required, particularly in relation to developmental and social factors 
influencing empowerment in CYP with CF. This could further explore how CYP manage 
competing priorities, and what helps them make complex decisions; how mastery and 
competence are experienced by CYP with CF at different developmental stages; and the role 
of adult others around them in facilitating this. 
 
Strict infection control guidelines have been in place since the mid-1990s, and further 
research might investigate whether peer support occurs in the context of these restriction, as 
well as the nature and impact of such support. 
 
CYP with CF are not only patients, but studies included in the current review primarily 
described indicators of empowerment in medical contexts. The term ‘patient empowerment’ 
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has been criticised for being over medicalised (Johnston-Roberts, 1999) – and it would be 
valuable for future research to explore empowerment across domains. 
Conclusion 
This synthesis of qualitative studies provides an initial insight into experiences of CYP with 
CF relating to patient empowerment – a topic which is currently under-researched.  
 
Through the process of thematic synthesis, the review identified a number of key themes 
relating to the process of empowerment in CYP with CF. Having relational support, 
information and understanding, feeling heard and respected, and experiencing mastery and 
competence were identified as factors that may facilitate empowerment. Prejudices and 
assumptions, particularly bullying or differential treatment were identified as potential 
barriers to empowerment. The findings of the review also suggested that navigating the 
impact of difference on self and facing limitations both influence and are influenced by 
empowerment.  
 
Whilst some of the findings resonated with previous reviews exploring empowerment in 
relation to adults with a range of LTCs, the review also suggests that the process of 
empowerment may be influenced by both developmental changes and stages and factors 
unique to CF.  
 
Findings need to be treated with caution as studies varied in quality. Overall, studies used 
appropriate research designs and methods for helping children to express their views, but the 
reporting of data analysis processes varied considerably. Across studies, the lack of 
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researcher reflexivity was a significant limitation, impacting on the validity of the findings 
reported.  
 
Nonetheless, there are both clinical implications and a clear need for further qualitative 
research to more fully understand the contextual and developmental influences on 
empowerment in CYP with CF. 
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Part B 
Abstract  
 
Whilst the importance of patient empowerment is increasingly being recognised, little is 
known about empowerment in children and young people (CYP) with long term conditions. 
Empowerment may be particularly important in CYP with cystic fibrosis (CF) due to high 
treatment burden and limited opportunities for peer support. 
 
This study employed a Grounded Theory Method to develop a preliminary theory of 
empowerment in CYP with CF. Seven CYP with CF, five parents and four professionals were 
interviewed. 
 
The emerging model suggests that ‘thriving alongside CF’ may be supported by interactions 
between ‘having a team’ and ‘taking charge and having a voice’, leading to ‘being able to just 
be a child/getting on with life’, that ‘concealing self’ may get in the way of ‘thriving 
alongside CF’ and that these processes occur within wider medical and developmental 
contexts. Study limitations, clinical and research implications are discussed. 
 
Key words: Cystic Fibrosis, Empowerment, Adolescents, Children 
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Introduction 
Patient empowerment 
 
Supporting increasing numbers of people living with long-term conditions (LTCs) is 
challenging for the NHS (Goodwin, Sonola, Thiel, & Kodner, 2013). Since the 1990s, policy 
has shifted towards collaborative healthcare models, with policies now referring to patient 
empowerment to enable patients with LTCs to better manage their health and achieve better 
outcomes (Small, Bower, Chew-Graham, Whalley, & Protheroe, 2013). Empowering patients 
is consistent with NHS values, e.g. ‘improving lives’ and ‘respect and dignity’ (Department 
of Health, 2015). However, clear definitions of patient empowerment are lacking, and the 
concept has been found to overlap with other concepts including self-efficacy, self-
determination, self-management and autonomy (Cerezo et al., 2016). 
 
Most patient empowerment literature has been written from a nursing perspective (Coyne, 
2006; Gibson, 1991). Psychological theories of empowerment come largely from community 
psychology, e.g. Rappaport (1984) and Zimmerman (1995). There are several models of 
patient empowerment, though arguably, the most relevant to patients with LTCs is that of 
Bravo et al. (2015). This was based on interviews with key stakeholders: adults with various 
LTCs, health managers and researchers. Self-efficacy, knowledge and skills, perceived 
control, a sense of meaning, and feeling respected were identified as indicators of 
empowerment. Bravo et al. (2015) suggested empowered adult patients participate in shared 
decision-making, self-manage, and utilise support groups.  
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Much of what is known about patient empowerment focuses on adults. Although there is 
growing interest in patient empowerment in adolescents and a scale of empowerment has 
recently been developed for children and young people (CYP) with LTCs, this has been 
based on an adult patient empowerment model (Acuña Mora et al., 2018). Patient 
empowerment in relation to CYP is complex due to constant developmental changes, the 
relatively greater impact of systemic influences such as parents, teachers, and peers  (Kirk et 
al., 2013) and the influences of the wider social contexts that impact CYP indirectly including 
cultural patterns and values, dominant beliefs and ideas, as well as political and economic 
systems (Bronfenbrenner, 1986). Empowering CYP with LTCs is essential for future 
engagement and has potential to impact significantly on long-term health outcomes. This is 
particularly important in cystic fibrosis (CF) due to the significant treatment burden and 
barriers to face-to-face peer support associated with risks of cross-infection (Cystic Fibrosis 
Trust, 2019). 
 
Cystic fibrosis 
 
CF is a multisystemic condition primarily affecting the lungs and digestive tract (Cystic 
Fibrosis Trust, 2019). CF is the most common life-limiting genetic condition affecting white 
populations: one in every 2,500 babies born in the UK have the condition (Cystic Fibrosis 
Trust, 2019; R. Williams & Barker, 2010). Fifty years ago it would have been unlikely for a 
child with CF to live to their 10th birthday (Coulthard, 2018). With universal screening, 
earlier diagnosis, new understandings and treatments there have been dramatic increases in 
life expectancy with over half of people with CF living beyond the age of 47 (Cystic Fibrosis 
Trust, 2019). 
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CF has a high treatment burden: daily therapies typically include chest physiotherapy, 
nebulised medication, pancreatic enzymes, nutritional supplements and antibiotics (Cystic 
Fibrosis Trust, 2019). Whilst there is variation in disease severity and progression, many 
individuals require frequent inpatient treatment throughout their lives. 
 
Dramatic increases in life expectancy have opened up both new possibilities and new 
problems for CYP growing up with CF. Whilst people with CF live longer, they are often 
affected by significant morbidity (Coulthard, 2018). Improved survival means that they and 
their families must cope with the demands of living with the condition for longer, managing 
increasingly complex regimens (Sawicki et al., 2013).  
 
Although there is some disagreement within the literature, it appears that the additional 
psychosocial challenges associated with having CF increase the risk of experiencing 
psychological distress (Cruz et al., 2009). 
Developmental perspectives 
 
According to Erikson’s model of psychosocial development (1959), identity verses role 
confusion is the key conflict to be resolved during adolescence. For CYP with LTCs, 
adolescence is characterised by multiple physical, cognitive, social and emotional changes 
that must be negotiated alongside the medical condition (Sawyer, Drew, Yeo, & Britto, 
2007). This often includes learning to accommodate the condition and accepting more 
responsibility for managing self-care into adulthood (Stein, 1992).  
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Little is known about the influences on and impact of empowerment in CYP with CF during 
adolescence, a period associated with life transitions such as changing schools, becoming 
more independent at home, developing friendships and romantic relationships, forming an 
independent sense of identity and planning for the future (Erikson, 1959). For adolescents 
with CF this period of rapid developmental change often coincides with worsening CF 
symptoms, e.g. cough and fatigue, increasingly frequent pulmonary exacerbations (episodes 
of intense disease activity) and associated increases in treatment burden (Hegarty et al., 
2009). At a time when CYP would otherwise be becoming more independent and spending 
time with friends, deteriorating health could make them become isolated and more dependent 
on family, needing to stay at home or being admitted to hospital (Iles & Lowton, 2008). 
 
Historically, CYP with CF benefited from peer support through residential social events. This 
helped to reduce isolation, protected against stigmatisation and increased quality of life 
through the sharing of adaptive coping strategies. In the mid-1990s, the dangers of cross-
infection were recognised, resulting in strict infection control policies, including guidance 
that patients should never meet in person (Rowbotham, Palser, Smith, & Smyth, 2019). 
 
Rationale 
 
In summary, empowering patients is consistent with the aims and values of the NHS. Much 
of what is known about patient empowerment relates to the experiences of adult patients. Due 
to medical advances there have been dramatic increases in longevity amongst patients with 
CF, a condition with a high treatment burden, typically diagnosed at birth. To the author’s 
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knowledge, there are no existing studies of empowerment in CYP with CF. Given that current 
theory is insufficient, it was felt helpful to use grounded theory (Corbin & Strauss, 2015) to 
develop new theory rather than attempt to force data into existing theories of patient 
empowerment that have largely been developed from experiences of adult patients with other 
LTCs. 
 
Aim 
 
This study aimed to develop a grounded theory of perceived facilitators of, barriers to, and 
consequences of empowerment in CYP with CF during key life transitions. 
Research questions: 
1) How do CYP with CF experience empowerment during key life transitions?  
2) What are the perceived facilitators of empowerment during these transitions? 
3) What are the perceived barriers to empowerment during these transitions? 
4) What are the perceived consequences of empowerment during these transitions? 
 
Method 
 
Design overview 
 
A qualitative approach was adopted to enable a detailed exploration of participants’ views 
and experiences. Grounded Theory Birks and Mills (2015) was selected as a methodology 
that can be particularly useful where little is known about the study area, where the 
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phenomena of interest involves a process, and where developing new theory with explanatory 
power is a desired outcome. 
 
Interviews were conducted using semi-structured interview schedules, giving focus to the 
interviews while allowing participants freedom to describe their subjective experiences in 
their own words. This method, along with line-by-line analysis of the data, aimed to give a 
voice to CYP with CF and the adults that support them (Charmaz, 2006). 
 
Epistemological position 
 
Grounded theory can be conducted from a range of philosophical and methodological 
positions (Birks & Mills, 2015). This study employed a critical realist approach, assuming 
that whilst an objective reality exists, it can only be made sense of and described through the 
lenses of language and social context (Oliver, 2012). This approach suited the researcher’s 
philosophical standpoint and is likely to have more utility than a social constructionist 
perspective in medical settings, which tend to be predominantly realist.  
 
Patient and public involvement 
 
Feedback was sought from the Cystic Fibrosis Trust (UK based charitable organisation) 
patient and public involvement (PPI) lead, suggesting that research into empowerment in 
CYP with CF, would be of interest to its members. CYP from a youth advisory panel (based 
at a children’s hospital not involved in the research) commented on the CYP information 
sheets, assent/consent forms and draft interview schedules. Feedback was incorporated into 
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final versions of these documents. Attempts were made to gain similar parental input, 
however this was hampered by the local PPI group disbanding. 
Sampling 
 
Following principles of grounded theory, sample size was not prospectively determined. Data 
collection and analysis was conducted concurrently, later participants were recruited 
according to the likelihood that they would be able to answer questions raised by earlier 
interviews and fill gaps in the emerging theory including possible exception (theoretical 
sampling). Participants were continuously recruited on the basis of theoretical sampling until 
no new concepts arose during analysis of successive interviews. See Appendix E for a flow 
chart detailing theoretical need for participant selection and the order in which this occurred). 
 
Strauss and Corbin (1990) used the term ‘theoretical saturation’ to describe the point where 
no new codes are identified in later rounds of data collection, and where categories are 
developed to the point that properties (characteristics) and dimensions (variations) of all  
categories are well defined and integrated within the model. Dey (1999) highlighted the 
subjective nature of ‘theoretical saturation’, arguing that data collection and analysis could go 
on indefinitely and researchers should instead be aiming for ‘theoretical sufficiency’. 
Theoretical sufficiency is the point at which the emerging theory is considered to have good 
explanatory power.  
 
Following joint coding of extracts from several transcripts with trainee research peers, asking 
questions such as ‘what processes are occurring here?’ and ‘when, why and how does the 
process change’ (Charmaz, 2006, p. 51) and discussion about developing categories in 
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supervision, theoretical sufficiency was considered to be attained at 14 interviews; two 
subsequent interviews yielded no new concepts. 
Participants 
 
Participants were recruited from two NHS paediatric CF services in England. One service 
was based within a children’s hospital where patients typically transferred to adult CF 
services aged 17-19; the other was based within a large regional hospital where patients 
typically transferred at 16. 
 
The researcher attended multi-disciplinary team meetings to introduce the research. CF teams 
were emailed information (Appendix F), including information sheets (Appendices G-J), and 
consent/assent forms (Appendices K-N). Eligible participants recruited via the NHS were 
identified by CF clinicians using clinic databases. Inclusion/exclusion criteria are shown in 
Table 1. 
 
As recruitment was initially slower than expected, further ethical approvals were obtained to 
expand recruitment to CF charities and social media, though this did not recruit further 
participants. The main barriers to participation were thought to be pre-existing pressure on 
CYP and their families due to the high treatment burden of CF, and competing requests for 
biomedical research with greater personal benefit (e.g. inclusion in novel drug trials).  
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Table 1 
Inclusion and exclusion criteria 
Inclusion 
 
Exclusion 
Children and young people (CYP) aged 
11-19 years with a diagnosis of cystic 
fibrosis (CF) 
 
Parents/guardians of eligible CYP 
 
Professionals working with CYP with 
CF 
 
Under the care of (CYP with CF) or 
known to (professionals and 
parents/guardians) an NHS paediatric 
CF team in the UK 
Insufficient command of English 
language or cognitive difficulties that 
would affect the interview process. 
 
CYP person has significant non-CF 
related co-morbidities 
 
Families considered by clinical team to 
be currently too vulnerable (for 
whatever reason) to participate in 
research. 
 
Families associated with significant 
risks identified by the clinical team (e.g. 
risk of aggressive behaviour). 
 
Professional has under six months’ 
experience of working with CYP with 
CF. 
 
CYP who have already transferred to 
adult CF services. 
 
Professionals working solely in adult CF 
services 
 
Sixteen participants were included in total; participant demographic and health information 
are shown in Tables 2-4 (data amalgamated to protect confidentiality).  
 
 
Table 2  
Young person demographic and health information 
Age Range: 12-18 Mean: 14.7 
Gender Male: 3 Female:4 
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Ethnicity White British: 7  
Age at CF diagnosis Newborn: 4 
≤ 2 years: 2 
? ≤ 5 years: 2 
FEV-1a Range: 79 – 122% Mean: 100.5% 
CF related comorbidities & procedures CF related diabetes; intestinal obstruction; 
gastrostomy; ACE procedure; ileostomy; 
lobectomy; microcytic anaemia 
Number of episodes of IVs in previous year Range: 0 – 4 Mean: 1.5 
Number medications Range: 5 – 15 Mean: 11 
 
a FEV1 (forced expiratory volume in 1 second) is a measure of CF disease severity. An FEV1 
of 100% means that lung function is as would be expected for a person of the same age and 
height who doesn’t have CF. FEV1 ≥ 85% is considered normal; 70-84% indicates mild lung 
disease, 41-69% indicates moderate lung disease; ≤ 40% suggests severe lung disease (UK 
Cystic Fibrosis Registry, 2013). 
 
Table 3 
Parent/carer demographic information 
Relationship to child with CF Father: 1 Mother: 4 
Gender Male: 1 Female: 4 
Ethnicity White British: 5 
Age of children Range: 11-18 Mean: 13.8 
 
 
Table 4 
 
Professional demographic information 
Profession Dietician 
Physiotherapist 
Specialist nurse 
Pharmacist 
 
Years of experience 1-5 years: 1 
6-10 years: 1 
11+ years: 2 
 
Interviews 
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A flexible interview schedule was developed in accordance with the research questions. 
Interviews took place on NHS premises, familiar to participants or via telephone. Duration 
was from 17-56 minutes. Participant comfort was prioritised; CYP were first asked about 
their general interests to build rapport (Charmaz, 2006). Similarly, to ease adult participants 
into the interview process, initial questions were more general and related to CYP’s interests. 
Initial interview schedules for each interview group are included as Appendices O-Q. Topics 
included: times when CYP feel most confident, accessing information, handling change, 
managing CF treatment, hopes for the future and messages for people wanting to help CYP 
feel more empowered. 
 
To avoid social desirability and accommodate varying cognitive and developmental levels, 
concrete questions were initially used, progressively addressing more abstract concepts. 
Intermediate questions were designed to be unobtrusive and flexible; questions were guided 
by participants’ responses and appropriate prompts used throughout. This flexible approach 
enabled detailed exploration of experiences and helped prevent the researcher imposing 
preconceived ideas (Charmaz, 2006). Final questions moved away from more sensitive 
experiences which was deemed particularly important for younger participants.  Throughout 
the interviews, reflection and paraphrasing were used to check for inconsistencies within the 
data and clarify meaning.  
 
All interviews were audio-recorded and professionally transcribed (see Appendix R for 
confidentiality agreement). 
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Ethical considerations 
 
Ethical practice was guided by the BPS code of human research ethics (The British 
Psychological Society (BPS), 2014) and the BPS code of ethics and conduct (BPS, 2018).  
 
Ethical approval was granted by a local NHS ethics committee (Appendices S-T) and the 
Health Research Authority [HRA] (Appendix U). Research and development (R&D) 
approval was granted by two NHS Trusts (Appendices V-W). 
 
Informed consent/assent 
 
Families and professionals were introduced to the researcher by a member of the CF team. 
The researcher explained the study and answered any questions. This included details about 
confidentiality, rights to withdraw from the study and storage and use of data. Information 
was also provided in written format (Appendices G-J).  
 
Potential participants were given a minimum of 24 hours to decide whether to participate.  
Children under 16 whose parent/guardian had given consent were asked for their assent, 
particular care was taken to avoid children feeling undue pressure to participate. Over 16s 
consented for themselves. 
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Managing potential harm to participants 
 
As talking about empowerment/disempowerment in the context of growing up with CF can 
be sensitive, the study was designed such that participants were only exposed to experiences 
that were already known to them (their own experiences or experiences that they had 
witnessed or been told about relating to their child or a child that they had cared for 
professionally). No participant was required to discuss anything they were uncomfortable 
with. 
 
Local CF specific infection control policies were complied with at all times, e.g. participants 
with CF were not seen back-to-back in the same room, nor asked to wait in the same waiting 
area as others with CF. 
 
To increase convenience and reduce infection risk, all participants were given the opportunity 
to provide written consent electronically and to participate in interviews via 
videoconferencing or telephone if preferred. 
 
Special considerations – working with children 
 
Given the specific ethical and methodological issues raised with conducting research with 
and for CYP, care was taken to explain the research in an accessible way, to avoid ‘pseudo-
friendships’ and to acknowledge and minimise power differentials between researchers and 
young participants (Oakley, 1994). 
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Data analysis 
 
The data were analysed using grounded theory as described by Corbin and Strauss (2015). 
This approach was in line with the epistemological stance of the researcher and has 
previously been used in research exploring the experiences and perspectives of individuals 
with physical health conditions (Corbin & Strauss, 1991). This method utilises three stages of 
coding: open, axial and selective. This process is outlined in Table 5; a more detailed coding 
table and example transcript are included in Appendices X-Y. 
Codes were continuously reviewed throughout data analysis, particular efforts were made to 
find comments appearing to contradict the developing theory, consider alternative 
interpretations, and adjust codes accordingly. The NVivo 12 software package was used to 
facilitate data analysis. 
 
 
Table 5 
Description of the analytic process 
Initial ‘open’ coding Audio files were checked against verbatim transcripts and 
coded line-by-line enabling the researcher to become 
thoroughly immersed in the data. 
 
This initial coding was used to break the data down and allow 
segments to be compared with other segments, between and 
across transcripts (Glaser & Strauss, 1967). 
 
During open coding the researcher stuck closely to the data 
and was particularly careful to reflect on their own 
assumptions when making early analytical decisions (Corbin 
& Strauss, 2015). 
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Concurrent data 
collection and 
analysis 
Data was analysed after each interview.  
 
In each case the researcher asked ‘what is the data saying and 
where are the gaps?’ (Glaser & Strauss, 1967).  
 
On the basis of this, interview questions were refined and 
‘theoretical sampling’ was used to identify which other 
potential participants to interview. 
Theoretical 
sampling 
Additional participants were recruited according to likelihood 
that they would be able to answer some of the questions 
raised by other interviews (Birks & Mills, 2015). 
Intermediate ‘axial’ 
coding 
Axial coding was used to reassemble the data that was 
fractured during open coding at a more conceptually abstract 
level (Corbin & Strauss, 2015).  
 
First categories were developed by linking subcategories and 
considering their properties and dimensions. Categories were 
then linked together (Birks & Mills, 2015). 
 
The main question here was what are the relationships 
between categories (who, what, when, and how) (Corbin & 
Strauss, 2015). 
Selective coding and 
theoretical 
integration 
Core category identified and systematically related to other 
categories (Corbin & Strauss, 2015). 
 
Storyline technique used as a mechanism for theoretical 
integration (Corbin & Strauss, 2015). 
Theoretical 
sensitivity 
Idea that all researchers have their own way of seeing the 
world, influenced by their own experiences and things 
they’ve read.  
 
As data analysis progresses, they will become more sensitive 
to emerging concepts that resonate with their own previous 
experience 
Memo writing and 
diagrams 
Diagrams and memos were used to note emerging ideas and 
track theory development, acting as a bridge between data 
collection and theoretical analysis.  
 
Memos are used throughout the process to record initial 
reflections, and as analysis continued links between 
increasingly abstract concepts (Birks & Mills, 2015). 
Constant 
comparison 
Throughout the process data was constantly compared within 
and between all three levels of coding and across memos. 
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Quality assurance 
 
There is a lack of consensus around criteria and processes for evaluating qualitative research 
(Thomas & Harden, 2008). This report was guided by a tool for appraising qualitative 
research developed by the Critical Appraisal Skills Programme [CASP] (Public Health 
Resource Unit, 2006), guidance provided by Mays and Pope (2000), and the principles of 
good practice for conducting research with children described in Thomas et al. (2003).  
 
In keeping with the critical realist stance, researcher reflexivity was prioritised. Reflexivity 
refers to the consideration of the ways that the researcher’s prior experiences, biases and 
assumptions may impact on the research process at all levels from initial proposal to 
dissemination (Mays & Pope, 2000). The researcher was mindful of how her own 
preconceptions might influence the research. She mitigated the projection of her own 
understandings through the use of a research diary (Appendix Z), bracketing interviews 
(Appendix AA), active listening, adhering closely to the data and making constant 
comparisons within and between transcripts. While the researcher did not discuss her own 
health with participants, her own visible disability may have affected participants’ disclosures 
during interviews and allowed greater sensitivity to some of the socially contextualised 
concerns participants raised. 
 
Triangulation between interviews with CYP, parents and professionals, and the use of 
diagrams (Appendix BB) and theoretical memos (Appendix CC) also added 
comprehensiveness and supported researcher reflexivity (Mays & Pope, 2000) 
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Feedback to stakeholders 
 
Findings were shared with relevant stakeholders including: NHS ethics committee, HRA, 
relevant R&D departments (Appendix DD); all participants (Appendix EE); and services in 
which the research was conducted. 
 
Results 
 
Due to space constraint, some subcategories will be described in more detail than others. The 
focus will be on categories that address the research questions most directly, the aspects that 
are not explained in previous literature, and those that are most relevant for clinical practice, 
future research and policy.  
 
 
Table 6:  
Selective and axial codes 
Selective code Axial codes 
Having a team Team membership 
Provides a sense of acceptance/ ‘normalising’ 
Share burden of CF 
Makes room for mistakes/ learning from experience 
Trusting relationships 
Taking charge 
and ‘having a 
voice’ 
Information and understanding 
Active participation in decision-making 
Explaining to others 
‘Finding ways round and through’/ practical problem solving 
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Being able to just 
be a child/getting 
on with life 
Self-acceptance/dealing with difference 
Achieving in relation to own goals 
Having fun and adventures 
Concealing self Other people’s assumptions 
Difficulties fitting it all in 
Concealing self 
Unheard voices 
Wider context Unique individuals 
Interaction with developmental changes and stages 
Constantly changing landscape of CF 
 
Overview of the model 
 
The model presented in Figure 1 illustrates the phenomenon of ‘thriving alongside CF’. 
Categories and subcategories are highlighted in bold. Quotations were selected to best 
represent the categories while demonstrating the range of views expressed, and are italicised 
in the text. 
 
 
Develops 
Requires 
Lim
its 
Enables 
Enables Enables 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Having a team 
(at least one 
significant 
confiding 
relationship) 
Concealing 
self 
Being able to 
just be a child 
/ getting on 
with life 
Taking charge 
and ‘having a 
voice’ 
Wider context: - Unique individuals;  
- Interaction with developmental changes;  
- Constantly changing landscape of CF 
Other 
people’s 
assumptions 
Difficulties 
fitting it all 
in 
Acceptance 
of 
difference 
Achieving in 
relation to 
own goals 
Having fun 
and 
adventures 
Unheard 
voices 
Information 
and 
understanding 
Active 
participation in 
decision-
making 
Explaining 
to others 
‘Finding 
ways round 
and 
through’ 
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The core category that emerged from the data was ‘thriving alongside CF’. Five higher level 
categories (selective codes) appeared to influence ‘thriving alongside CF’: having a team, 
taking charge and having a voice, being able to just be a child/getting on with life, 
concealing self and the wider context. 
 
Two higher level categories appeared to support ‘thriving alongside CF’: having a team, 
and taking charge and having a voice. These categories seemed to interlink with each other 
and enable being able to just be a child/getting on with life. 
 
Concealing self appeared to obstruct ‘thriving alongside CF’ because having to conceal 
oneself limits having a team and being able to just be a child/getting on with life. 
 
‘Thriving alongside CF’ also appeared to be influenced by wider contextual factors. 
‘Thriving alongside CF’ occurs in the context of constant developmental changes, changes 
in the condition and treatments at the individual level, and constant developments in 
biomedical understandings and CF treatment. 
 
Core category 
The core category which links all the data together is ‘thriving alongside CF’. This refers to 
CYP being able to live without their diagnosis defining them or preventing them from 
making choices that impact on how they live.  
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‘they’re happy… they live their life, and CF is a part of it, but CF isn’t their whole 
life’ (Professional) 
 
Professionals noted that there is a group of CYP with CF who aren’t currently ‘thriving 
alongside CF’. Due to the nature of this research, these voices remain silent and are referred 
to as ‘unheard voices’. 
 
Having a team 
 
All participants referred to the importance of CYP with CF having a support network. CYP, 
parents and professionals all used ‘team language’ for example ‘we’re very much a team’ 
giving rise to the in vivo code (codes that place the emphasis on the words spoken by 
participants) ‘having a team’. 
 
Team membership 
 
Family, friends, the medical team, and school were key members of the team for many CYP. 
For some, a connection with God and a faith community were important, for others, sports 
clubs or pets.  
Trusting relationships 
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All participants referred to the importance of trusting relationships. CYP and their families 
valued enduring friendships and consistency of medical team members. 
 
 ‘it’s a good feeling when there’s someone there who’s been with you since you were  
 born’ (YP 17, M) 
 
Having a team of trusted people facilitated open and honest conversations. Whilst having 
friends in general was beneficial having ‘at least one good friend’ seemed particularly 
important and links to the subcategory (axial code) of ‘explaining to others’.  
 
‘Get a really close friend… one person you can really trust and tell them’ (YP 15, F) 
 
CYP varied in how open they were about CF. Some chose to tell one or two carefully 
selected friends or teachers on a strictly need-to-know basis.  
 
‘I mean, we’ve got some children who… have… a couple of best friends who know…  
they don’t want it blazoned across… for all in sundry to hear about it.’ (Professional) 
 
Others spoke proudly of the confidence they had gained through standing up in front of large 
groups and raising awareness of CF, for example in assemblies at school  
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 ‘Once it was off my chest I felt so much better, and they know what I'm going through  
 and why I'm missing school so much’ (YP, 13 F) 
 
Having ‘at least one good friend’ protects against ‘having to keep secrets’/concealing self.  
 
‘we definitely see a difference in the children who, for example… haven’t told their 
friends at school and have to take their Creon in secret and they find that it’s… 
always stressful’ (Professional) 
Sharing the burden of CF 
 
CF was described by CYP and parents as too much for any one person to manage. 
 
‘It's so important that it's not just down to us parents, it's not just down to [child], it's 
a team effort, work with the CF team as well, you've got their support, their backing, 
their help, their guidance.’ (Parent) 
 
The CYP’s team has several roles which may be fulfilled in different ways by different 
members at different times. Several participants described how having a team helped share 
the burden of CF through practical and emotional support. 
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‘If I’m down… the dumps, my family and my friends always help me out. And my little 
pet lizard always keeps me calm’ (YP, 12, M) 
 
Several CYP explained that although they completed all aspects of their CF regime, doing all 
of the CF-related tasks completely independently was not their priority. Sharing the burden of 
CF with help from family, friends and the medical team to complete tasks provided CYP with 
the time and energy to do other things that were important to them. 
 
‘I can do my IVs myself, but I choose not to… My mum will do them if I’m at home. 
But if I’m in hospital, the nurses will.’ (YP, 18, F) 
 
For some CYP the CF community formed an important part of their team  
 
‘It’s nice to know that people have the same thing and that can relate to… what we’re 
going through’ (YP, 14 M) 
 
Others expressed a yearning for connection with other CYP with CF. 
 
‘I know absolutely no-one whatsoever… I would love to know someone my age and 
talk to them…  – not necessarily about CF – but talk to someone daily, how you would 
talk to anyone else that’s in the same position as you. Because you can have really 
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supportive people around you, really amazing people, but they’re not in the same 
position as you’ (YP, 14 F) 
Providing a sense of acceptance/’normalising’ 
 
One of the team’s roles was providing a sense of acceptance. Many CYP spoke of the 
importance of feeling ‘normal’. Feeling accepted at home, with friends and at school was 
experienced as ’normalising’ by many CYP. 
 
‘I’d class my friends as normal, when I’m out with them not worrying about my 
health, like I’m not doing my medication then, I’m not in hospital then, I’m more 
classed as normal, and that’s quite nice.’ (YP 18, F) 
Making room for mistakes and learning from experience 
 
Another theme that emerged, primarily from interviews with parents and professionals, was 
the team’s role in making room for mistakes and allowing CYP to learn from experience. 
This was the case both in relation to the lessons CYP needed to learn for themselves (as 
opposed to being told) in directly managing CF, as well as generic learning experiences 
which would have an added layer of complication for CYP with CF. 
 
‘I’ve certainly had a couple of chats about alcohol with our older teenagers. It’s 
generally quite positive. They’re teenagers, they’re going to experiment…. So I try 
really hard to show that I’m not judging them and I’m not going to tell them off.’ 
(Professional) 
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Some of the professionals reflected on how taking on the role of a coach facilitated the CYP 
taking charge. 
‘team members to act like coaches, and to allow the children, as they get older… to 
feel like they can ask really simple questions, and... can tell us and be honest about 
their compliance with treatments… and be honest about when they’re really 
struggling.’ (Professional) 
 
Many of the adult participants described how allowing CYP to learn from experience both 
required and built trusting relationships.  
 
‘Whatever’s going on, we can support you and if you want to make a change or get 
back on track, whatever direction you want to take following whatever’s happened, 
we’re here to support you’ (Professional) 
 
Several parents and the three oldest CYP with CF reflected on the role that their families and 
medical team had in enabling learning from experience. 
 
‘he knows if he doesn’t take his medication he will get poorly… cos he’s tried it once 
before, he’s hidden his tablets when he was younger’ (Parent)  
 
‘stop badgering...Remind me a few times, but it’s on me if I don’t do it’ (YP, 17 M) 
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Taking charge and having a voice 
 
‘Having a team’ supports ‘taking charge & having a voice.’ All participants referred to 
taking charge and developing a voice, both directly in relation to the medical context and 
more broadly. This was something that interacted with developmental changes and evolved 
over time. Taking charge and ‘having a voice’ appeared to both require and develop 
information and understanding. 
 
‘I think if they take charge of it themselves… be more independent… understand it 
and do more treatments for themselves, I think that’s a big help for children’ (Parent)  
 
Professionals spoke of a wide range in levels of understanding about CF amongst the CYP 
that they work with. 
 
 
‘there’s a huge range of between what the level of detail they know about their 
condition’ (Professional)  
 
Professionals and parents noted the role of parents in passing on information about CF to 
CYP, with professionals in particular reflecting on how the informational needs of CYP 
change over time. 
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‘it’s quite up to the parents to give the information’ (Parent)  
 
‘Some of our parents are very open with their children about the condition and 
complications... Others are very secretive about it and they don’t want to talk about 
certain things in front of their children… they don’t want to worry their child about 
things that might happen’ (Professional) 
 
All professionals described strategies that they had developed to encourage CYP to take 
ownership of their own understanding of CF/CF treatments – for example developing tailored 
information sheets and encouraging CYP to ask questions in clinic. 
 
A number of CYP made references to the difference between getting information from 
professionals or information sheets and getting information from others with lived experience 
of CF. 
 
‘someone who has the experience to know… instead of… people who have either 
known people with CF or have just found things out from reading things. It would 
have been nice to have had a first-hand experience’ (CYP 14, M) 
 
Approximately half of the CYP interviewed were connected to other CYP with CF through 
internet based support groups which acted as a source of information and social interaction. 
For those who did not have any contact with others with CF, this was experienced as a loss 
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with CYP feeling they were missing out on an important source of information and 
connection. 
 
 ‘Because I’m not allowed near any other person with it… it’s a bit concerning, and  
upsetting… then I can’t talk to people who understand what I’m going through’ (CYP 
12, M) 
 
A range of views were expressed by parents and professionals about information from the 
internet, including from support groups. Some had had their own positive experiences of 
connecting with others in similar circumstances; others feared that support groups could be 
the source of frightening or inaccurate information, or encourage non-compliance.  
 
‘she’s quite well informed but I don’t think she knows everything, all the different 
paths that the future could lead to…. if you connect with other people you don’t know 
what they know… she’s still very young, in terms of having to sort out if some people 
are rebelling against regimes… I’m just wondering if that’s unhelpful as well as 
helpful.’ (Parent ) 
 
Having information and understanding seemed to enable taking charge and having a voice 
which in turn seemed to enable active participation in decision-making. 
 
‘I think the first step is understanding what it is… and from there, you can make 
choices’ (CYP 15, F) 
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Many participants stressed the importance of having information so that the CYP could make 
decisions based on their individual preferences and circumstances. This included both 
treatment-related decisions such as medication regime timings and broader life decisions such 
as career choices. 
 
‘Taking control of their CF and being able to have a voice in the management and 
direction that they take…being able to manage it alongside all the rest of their life… 
to make the decisions that help them direct their journey through it’ (Professional) 
 
Taking charge and ‘having a voice’ appeared to enable ‘finding ways round & 
through’/practical problem solving. All of the CYP and parents gave examples of finding 
ways of doing the things that are important to them despite the significant challenges that CF 
and associated treatment regimens can present. For many, having a routine facilitated this. 
Others described emotional coping strategies and creative solutions to practical problems. 
 
‘We have done things like administering IV antibiotics in the car, before she went in 
to a party’ (Parent) 
 
Taking charge and ‘having a voice’ seemed to enable explaining to others which appeared to 
help counteract other people’s assumptions. 
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 ‘I basically said, “If I cough, it’s not contagious.” And as the weeks went on, they  
 found out a little bit more (YP 18, F) 
 
Taking charge and ‘having a voice’ appeared to enable ‘being able to just be a child/getting 
on with life’. 
Being able to just be a child/getting on with life 
 
‘Being able to just be a child/getting on with life’ seemed to be a consequence of ‘thriving 
alongside CF’. This was something that many of the CYP and their families strived for. 
 
‘our attitude is, that if you’ve done all your treatments then we can do anything else… 
let’s get everything done, out the way, forget about it, and now crack on with normal 
stuff’ (Parent) 
 
‘he needs to live a full life and be like any other child’ (Parent) 
 
‘Being able to just be a child/getting on with life’ seems to require ‘acceptance of difference’. 
 
‘if I never had CF, I would never be me’ (YP, 13 F) 
 
Acceptance of difference appeared to enable ‘achieving in relation to own goals’ and ‘having 
adventures and fun’ both of which were described as examples of ‘being able to just be a 
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child/getting on with life’. For some CYP, ‘achieving in relation to own goals’ meant 
spending time with friends, others accomplished this through sport or academic 
achievements, or through raising awareness about CF. 
 
‘recently where she is starting to feel more comfortable about herself, her body, how 
it looks, how she's feeling… she actually did a talk in one of her lessons’ (Parent) 
 
 ‘to be able to do all the things they want to do in life… relationship building or …a  
 particular career pathway’ (Professional) 
 
Concealing self 
 
‘Other people’s assumptions’ and/or ‘difficulties fitting it all in’ can put CYP in the position 
of having to making difficult choices and may lead to ‘having to keep secrets’ or concealing 
aspects of themselves. ‘Other people’s assumptions’ described by participants included 
misunderstandings about what CF is (e.g. contagious), low expectations (e.g. in relation to 
sport), and judgements (e.g. teachers and peers making comments about CYP with CF eating 
‘unhealthy’ foods, when in fact, a high fat / high calorie diet is medically necessary). 
 
All participants referred to the ‘difficulties fitting it all in’, and many CYP described arriving 
home exhausted and having to make a choice between completing homework or their full CF 
regimen. 
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 ‘it is hard to fit homework in as well as medicines’ (YP 13, F) 
 
Some referred to difficulties in having honest conversations with the medical team when it 
isn’t possible to fit everything in. This seemed to relate to fear of offending or disappointing 
the medical professionals that CYP and families valued so much as part of their team. 
 
 ‘I think she is quite conscious that everyone’s there to help her so she’s worried about  
 offending them if she appears ungrateful… she hates so many of her treatment… I  
 think she finds it hard to talk honestly about that without offending them’ (Parent)  
 
All of the professionals and some parents reflected on some CYP ‘having to keep secrets.’ 
This was described as stressful for the CYP and appeared to get in the way of ‘thriving 
alongside CF’  
 
 ‘they feel embarrassed about some of the things they have to do, and so they don’t tell  
 people. I think that… just increases the stress’ (Professional) 
 
‘Having to keep secrets/concealing self’ appeared to get in the way of developing ‘trusting 
relationships’ and seemed to limit ‘having a team’ as CYP may be unable to test out whether 
they will be accepted. 
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‘she felt quite embarrassed about that [side effect of medication] and so we were 
thinking about ways you could open up and own that a bit without feeling mortified. I 
don’t know if… you can ever… be so bold and say “… it’s my illness, it happens from 
time to time! Let’s all get over it and have a laugh and just move on”’ (Parent) 
 
The accounts of professionals and some parents suggested that ‘having to keep secrets’ may 
limit ‘active participation in decision-making’  
 
‘She will just nod and say yes and be polite. I don’t know how much she really feels 
able to really tell them [CF team] truthfully’ (Parent) 
 
Whilst some of the CYP reflected on times when they had felt that they needed to conceal 
aspects of themselves and keep secrets, the CYP interviewed spoke of this as something they 
had done in the past. A sense of the CYP currently feeling they have to conceal aspects of 
themselves (as opposed to those making an active choice to keep some information private) 
came through the professionals and parents of CYP who opted not to participate. This gave 
rise to the axial code ‘unheard voices.’ 
 
‘I guess it’s a bit of a shame… but it is the young people that do quite like to talk that 
have got involved [in the research] … it would be nice to hear their [those that didn’t 
take part] voice and for them to say, “Actually, I’m just completely pissed off with 
having CF and I don’t want to talk about it”.’ (Professional) 
 
Wider context 
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Thriving alongside CF was described by participants as occurring in the wider context of all 
CYP with CF being unique individuals, with unique constellations of experiences, hopes, 
fears, challenges, preferences and goals. 
 
‘It’s one of those things that people have their own… definition of. Like, what is 
empowering to one person won’t be to the other’ (YP 18, F) 
 
There also seemed to be an interaction with developmental stages and changes – CYP 
growing up with CF are constantly changing in terms of levels of cognitive, emotional and 
physical maturity. All participants spoke of the additional struggles faced by CYP with CF as 
they navigate the typical challenges of adolescence. Professionals in particular, highlighted 
the impact of uncertainty and the decline in health that many older adolescents face just when 
peers without CF will be in their physical prime. 
 
‘Puberty, changing peer groups, family dynamics, all those [things that]… children 
without CF, have to deal with… then I guess the changes in health that they may or 
may not suffer with’ (Professional) 
 
In addition to the constant changes in the condition and treatments at the individual level, 
‘thriving alongside CF’ also occurs in the context of constant developments in biomedical 
understandings of and treatments for CF.  Although this appeared important in maintaining a 
sense of optimism for the future for some participants, many CYP spoke of acceptance and 
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living more in the moment. Some spoke of difficulties in keeping up with constant medical 
developments 
 
 ‘It’s a bit confusing at first because when you’re used to the old stuff, then they give  
 you new stuff, I kind of get a bit worried that it’s gonna be hurting or… it’s not gonna  
 work because it’s brand new, and they’ve not tested it properly yet’ (YP, M, 12) 
 
Discussion  
 
Research has focused on parents and families of children with chronic conditions – few 
studies have focused on the children’s own perspectives (Carter et al., 2017). Five main 
themes emerged from the stories told by the CYP, parents and professionals about the process 
of ‘thriving alongside CF’: having a team, taking charge and having a voice, being able 
to just be a child/getting on with life, concealing self and the wider context. The model 
‘thriving alongside CF’ resonated both with broad psychological theories such as 
empowerment theory and social ecological theory, and with previous findings in CF-specific 
literature. 
 
Empowerment theory 
The model is consistent with Rappaport’s (1984) description of empowerment. Both 
Rappaport’s empowerment theory and the ‘thriving alongside CF’ model describe a process 
by which people gain mastery over their lives.  Rappaport asked the question ‘under what 
conditions do we find people reporting a sense of control over their lives?’ The model 
provides some answers to this question in relation to CYP with CF. Similarly to Rappaport, 
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the model suggested that there are often multiple possible solutions to challenges, that 
different solutions suit different individuals and that professional input may open up more 
possibilities. 
 
The model is also consistent with Zimmerman’s (1995) conceptualisation of psychological 
empowerment, in that ‘thriving alongside CF’ was found to take different forms in different 
CYP, can take different forms in different contexts (for example at home, at school and in 
clinic) and fluctuates over time. 
 
Zimmerman (1995) made the distinction between empowering processes (in which 
individuals are given opportunities to influence decisions that affect their lives and access to 
resources that enable them to move closer to their goals) and empowered outcomes (mastery 
and control, resource mobilisation and participation) both empowering processes and 
empowered outcomes are reflected in the model of ‘thriving alongside CF’.  
 
Other models of patient empowerment 
There was some overlap between the current model and models of patient empowerment 
based on research with adult patients (e.g. Bravo et al., 2015; Small et al., 2013), particularly 
in relation to having information and decision-making.  
 
There were also some significant differences. Some of these relate to developmental stages – 
for example feeling or being perceived to be ‘different’ and confronting other people’s 
assumptions are both likely to be more of a challenge for CYP than for adults, and children 
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are more likely to be dependent on adults for reliable sources of information (Ernst et al., 
2011). 
 
Other differences were specific to CF. For example the impact of infection control guidelines 
and the limited opportunities for some CYP to connect with others with CF (Vines, Fisher, 
Conniff, & Young, 2018) meant that the role patient peer support was more complex than is 
often reflected in models of empowerment based on other patient groups. 
Links to the CF literature 
The model is also consistent with previous research involving CYP with CF.  For example, 
Barker, Driscoll, Modi, Light, and Quittner (2012) described the importance of family and 
friends in successfully managing CF during adolescence. Parents in the Sawicki, Heller, 
Demars, and Robinson (2015) study made reference to the role of allowing adolescents to 
make and learn from mistakes in promoting adherence. Adolescents and their parents in 
Dashiff, Suzuki-Crumly, Kracke, Britton, and Moreland, (2013) acknowledged the 
importance of understanding the medical aspects of CF when making decisions, and 
highlighted a need to make information more accessible to children and their families. 
Children participating in  D’Auria, Christian, and Richardson (1997) study spoke of the 
process of deciding if and who to share information about CF with. However, in contrast to 
the current study, the D’Auria et al (1997) participants generally agreed that it was better to 
keep CF a secret. One explanation for this difference is that participants in the current study 
were older, indeed some reflected on having been afraid to tell their peers when they were 
younger.  
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There are numerous references in the literature to limited time and the burden of CF and CF 
treatment within the context of short lives (e.g. Barker et al., 2012; Foster et al., 2001). 
Whilst this clearly featured in the current study, there was much more of a sense of optimism 
and expectation of surviving and thriving into adulthood.  
 
In contrast to previous studies focusing on adherence in CF for example: (Sawicki et al., 
2015) the current study suggested that CYP taking full responsibility for CF care may be 
neither achievable nor desirable.  
 
What this study adds 
Increasing longevity associated with recent medical advances is affording many CYP living 
with CF opportunities not previously considered possible.  All participants made references 
to hopes for the futures of the CYP with CF. This included hopes for careers, getting married 
and having families of their own – all of which would have been unthinkable until relatively 
recently and are therefore not accounted for in much of the previous literature. 
 
Given the prominence of patient peer support in previous models of patient empowerment, it 
is particularly important to highlight the impact of infection control guidelines limiting 
physical contact between CF. These guidelines are still relatively recent and whilst other 
research on the impact of isolation is beginning to emerge (Vines et al., 2018) the current 
study adds an additional perspective. 
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To the author’s knowledge, the impacts of developmental stages and changes, the progressive 
nature of CF and the particularly rapid nature of current advances in CF care have not been 
accounted for in previous models of patient empowerment. 
 
Strengths and limitations 
 
Strengths of the current study included actively involving stakeholders (CYP and clinicians) 
in the design and implementation of the study, and the recruitment of participants from 
different groups (CYP, parents and professionals) across two hospitals.  
 
Whilst the recruitment of three separate participant groups enabled triangulation (Mays & 
Pope, 2000), and is likely to have encouraged greater reflexivity in data analysis, resulting in 
a more comprehensive understanding of ‘thriving alongside CF’, the limited scope of the 
project meant that it was only possible to recruit relatively small numbers of each category of 
participant. Consequently, although each category identified in the data was deemed to reach 
theoretical sufficiency, the theoretical model’s validity could be enhanced with a larger 
sample size.  
 
Data analysis was primarily conducted by a single researcher. Whilst analytic decisions were 
discussed in supervision and with research peers, and bracketing techniques were used, a 
second coder would have added to the validity of findings. Similarly, the validity of the 
model could have been enhanced through use of respondent validation (Mays & Pope, 2000). 
 
  
108 
 
Although participants were recruited from two NHS sites and attempts were made to also 
recruit via CF charities and social media, there remained a lack of diversity.  All participants 
were white British, to a certain extent this is consistent with the genetic predisposition of CF 
(Williams & Barker, 2010). Due to the complexities of measuring socio-economic stautus in 
CYP, this was not recorded, though it could be postulated to have an impact on CYP’s 
experiences of empowerment. 
 
The nature of the research is likely to have meant that CYP who are not currently ‘thriving 
alongside CF’ would be less likely to have the time, energy, confidence or inclination to 
participate. This group was alluded to by several participating professionals, and captured in 
the model under the category of ‘unheard voices’. This will be an important group to consider 
in future research.  
 
Implications for research 
It would be valuable to explore the extent to which the findings of the current study are 
transferable to other settings. This could be done by replicating the current study using larger 
samples. 
 
Previous work (Acuña Mora et al., 2018) has developed a scale of empowerment for children 
by applying a model that was originally developed based on research with adult patients. An 
advantage of the current model is that it is grounded in the views of CYP and the adults most 
closely involved in supporting them. A possible next step could be to develop a scale of 
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empowerment specifically for children with CF using a mixed method approach similar to 
those used by  Acuña Mora et al. (2018).  
 
The CYP who are not currently ‘thriving alongside CF’, whose voices are rarely heard in 
clinic and whom professionals most struggle to support provide a clear focus for future 
qualitative research.  
There is likely to be a need for creativity in considering how best to access this population, 
for example use of peer researchers as in Gathercole (2018) or use of anonymous 
questionnaires may go some way to mitigating power differentials between researcher and 
participants.  
 
Implications for clinical practice 
Given the importance ascribed by participants to ‘having a team’ it may be valuable for 
medical professionals to routinely ask CYP questions about who is in their support network 
and how CYP would like them to be involved. This could include questions about whether 
CYP have access to support from other CYP with CF. Access to peer support could be 
facilitated through the development of internet-based group interventions. 
 
The current study adds weight to recommendations previously made by Sawicki et al. (2015) 
for example developing communication tools for use by CYP and professionals that 
incorporate a mutual understanding of competing priorities and time pressures, and 
developing problem-solving skills using techniques such as motivational interviewing. This 
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could involve parents and professionals (including teachers), allowing choices, noting 
initiative and encouraging opinions and problem-solving.  
 
Clincians may find it helpful to continuously review with CYP’s understanding of CF and to 
develop a stock of accessible resources. Service evaluations could be conducted to 
understand the extent to which CYP feel they have the opportunity for ‘taking charge’ / 
‘having a voice’, e.g. using Likert scales.  
To support CYP with ‘being able to just be a child/getting on with life’ Acceptance and 
Commitment Therapy values-based work or motivational interviewing may help CYP make 
choices around CF-treatment and balance this with their social and educational activities. 
 
Conclusion 
 
This study drew on the experiences of CYP growing up with CF, their parents and 
professionals to develop a preliminary theory of empowerment during the key life transitions 
of adolescence. The emerging model suggests that ‘thriving alongside CF’ was supported by 
interactions between ‘having a team’ and ‘taking charge and having a voice’, leading to 
‘being able to just be a child/getting on with life’. ‘Concealing self’ gets in the way of 
‘thriving alongside CF’. ‘Thriving alongside CF’ itself occurs within a wider context. 
 
The model resonates strongly with models of empowerment developed within the context of 
community psychology (Rappaport, 1984; Zimmerman, 1995) but moves beyond existing 
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models of patient empowerment to incorporate both a developmental perspective and factors 
unique to CF. 
 
Given the relatively small-scale of the study it is important to treat findings with caution. 
However, there are important clinical and research implications. It may be possible to 
develop interventions to support CYP to have a voice and enable CYP with CF to develop 
their support network by connecting with each other virtually.  
 
Further qualitative and quantitative research should be undertaken to refine aspects of the 
model and test hypotheses, particularly in relation to the unheard voices of CYP not ‘thriving 
alongside CF’. 
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Part C Appendices A-LL 
CASP Checklist: 10 questions to help you make sense of a Qualitative research 
How to use this appraisal tool: Three broad issues need to be considered when appraising a 
qualitative study: 
  Are the results of the study valid? (Section A) 
  What are the results? (Section B) 
  Will the results help locally? (Section C) 
The 10 questions on the following pages are designed to help you think about these issues 
systematically. The first two questions are screening questions and can be answered quickly. 
If the answer to both is “yes”, it is worth proceeding with the remaining questions. There is 
some degree of overlap between the questions, you are asked to record a “yes”, “no” or 
“can’t tell” to most of the questions. A number of italicised prompts are given after each 
question. These are designed to remind you why the question is important. Record your 
reasons for your answers in the spaces provided. 
About: These checklists were designed to be used as educational pedagogic tools, as part of a 
workshop setting, therefore we do not suggest a scoring system. The core CASP checklists 
(randomised controlled trial & systematic review) were based on JAMA 'Users’ guides to the 
medical literature 1994 (adapted from Guyatt GH, Sackett DL, and Cook DJ), and piloted with 
health care practitioners. 
For each new checklist, a group of experts were assembled to develop and pilot the checklist 
and the workshop format with which it would be used. Over the years overall adjustments 
have been made to the format, but a recent survey of checklist users reiterated that the basic 
format continues to be useful and appropriate. 
Referencing: we recommend using the Harvard style citation, i.e.: Critical Appraisal Skills 
Programme (2018). CASP (insert name of checklist i.e. Qualitative) Checklist. [online] Available 
at:  URL. Accessed: Date Accessed. 
©CASP this work is licensed under the Creative Commons Attribution – Non-Commercial-
Share A like. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-
sa/3.0/ www.casp-uk.net  
Critical Appraisal Skills Programme (CASP) part of Oxford Centre for Triple Value Healthcare Ltd  www.casp-uk.net 
2 
Section A: Are the results valid? 
1. Was there a clear
statement of the aims of
the research?
Yes HINT: Consider 
• what was the goal of the research
• why it was thought important
• its relevance
Can’t Tell 
No 
Comments: 
2. Is a qualitative
methodology
appropriate?
Yes HINT: Consider 
• If the research seeks to interpret or
illuminate the actions and/or subjective 
experiences of research participants 
• Is qualitative research the right
methodology for addressing the
research goal 
Can’t Tell 
No 
Comments: 
Is it worth continuing? 
3. Was the research
design appropriate to
address the aims of the
research?
Yes HINT: Consider 
• if the researcher has justified the
research design (e.g. have they
discussed how they decided which 
method to use) 
Can’t Tell 
No 
Comments: 
Paper for appraisal and reference: ...............................................................................................................
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4. Was the recruitment 
strategy appropriate to 
the aims of the 
research? 
Yes  
 
HINT: Consider 
• If the researcher has explained how the 
participants were selected 
• If they explained why the participants 
they selected were the most 
appropriate to provide access to the 
type of knowledge sought by the study 
• If there are any discussions around 
recruitment (e.g. why some people 
chose not to take part) 
Can’t Tell  
 
No  
 
 
 
Comments: 
 
5. Was the data collected in 
a way that addressed the 
research issue? 
Yes  
 
HINT: Consider  
• If the setting for the data collection was 
justified 
• If it is clear how data were collected (e.g. 
focus group, semi-structured interview 
etc.) 
• If the researcher has justified the methods 
chosen 
• If the researcher has made the methods 
explicit (e.g. for interview method, is there 
an indication of how interviews are 
conducted, or did they use a topic guide) 
• If methods were modified during the 
study. If so, has the researcher 
explained how and why 
• If the form of data is clear (e.g. tape 
recordings, video material, notes etc.) 
• If the researcher has discussed 
saturation of data 
Can’t Tell  
 
No  
 
 
 
Comments:  
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6. Has the relationship 
between researcher and 
participants been 
adequately considered? 
Yes   HINT: Consider 
• If the researcher critically 
examined their own role, 
potential bias and influence 
during (a) formulation of the 
research questions (b) data 
collection, including sample 
recruitment and choice of 
location 
• How the researcher responded to 
events during the study and 
whether they considered the 
implications of any changes in the 
research design 
Can’t Tell  
No  
  
 
Comments: 
 
 
 
 
Section B: What are the results? 
 
7. Have ethical issues been 
taken into consideration? 
 
Yes  
 
HINT: Consider 
• If there are sufficient details of how the 
research was explained to participants for 
the reader to assess whether ethical 
standards were maintained 
• If the researcher has discussed issues 
raised by the study (e.g. issues around 
informed consent or confidentiality or how 
they have handled the effects of the study 
on the participants during and after the 
study) 
• If approval has been sought from 
the ethics committee  
Can’t Tell  
 
No  
 
  
 
Comments: 
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8. Was the data analysis 
sufficiently rigorous? 
Yes  
 
HINT: Consider  
• If there is an in-depth description of the 
analysis process 
• If thematic analysis is used. If so, is it clear 
how the categories/themes were derived 
from the data 
• Whether the researcher explains how the 
data presented were selected from the 
original sample to demonstrate the analysis 
process 
• If sufficient data are presented to support 
the findings 
• To what extent contradictory data are 
taken into account 
• Whether the researcher critically examined 
their own role, potential bias and influence 
during analysis and selection of data for 
presentation 
 
Can’t Tell  
 
No  
 
 
 
Comments: 
 
9. Is there a clear statement 
of findings? 
Yes  
 
HINT: Consider whether 
• If the findings are explicit 
• If there is adequate discussion of the 
evidence both for and against the 
researcher’s arguments 
• If the researcher has discussed the 
credibility of their findings (e.g. 
triangulation, respondent validation, more 
than one analyst) 
• If the findings are discussed in relation to 
the original research question 
Can’t Tell  
 
No  
 
 
 
Comments: 
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Section C: Will the results help locally? 
 
10. How valuable is the 
research? 
  
 
 
 
HINT: Consider 
• If the researcher discusses the 
contribution the study makes to existing 
knowledge or understanding (e.g. do they 
consider the findings in relation to current 
practice or policy, or relevant research-
based literature 
• If they identify new areas where research 
is necessary  
• If the researchers have discussed whether 
or how the findings can be transferred to 
other populations or considered other 
ways the research may be used 
 
 
 
Comments: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix B. Criteria for assessing research conducted with children used by (Thomas et al., 
2003) 
1. Did the study use appropriate data collection methods for helping children to express 
their views? 
2. Did the study use appropriate methods for ensuring the data analysis was grounded in 
the views of children? 
3. Did the study actively involved children in the design and conduct of the study? 
 
Appendix C. Key strengths and limitations of studies 
 
Key strengths and limitations of studies 
Study Strengths Limitations 
Ayers et al. 
(2011) 
 
Acknowledged those choosing 
not to participate 
Interview procedure 
appropriate for helping 
children express their views 
Researcher not associated with 
clinical team 
Clear consideration of ethics 
Data analysed by more than 
one researcher 
Clearly described process of 
thematic analysis and theme 
deduction 
Used appropriate methods for 
ensuring data analysis 
grounded in the views of 
children 
Quotes used to support 
findings 
Clear clinical and research 
implications  
 
No evidence of having 
involved children in design or 
conduct of the study 
Data saturation not discussed 
No evidence of researcher 
reflexivity 
 
Barker et al. 
(2011)  
 
 
Clear consideration of ethics 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Clear description of template 
analysis process 
Data analysed by more than 
one researcher, inter-rater 
reliability reported 
Quotes used to support 
findings 
Clear clinical and research 
implications 
 
No evidence of having 
involved children in design or 
conduct of the study 
Unclear how participants were 
selected by medical team 
Data saturation not discussed 
No evidence of researcher 
reflexivity 
Christian & 
D'Auria 
(1997)  
 
 
Clear description of grounded 
theory process 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Discussed data saturation 
 
No evidence of having 
involved children in design or 
conduct of the study 
No evidence of researcher 
reflexivity 
No reference to ethical 
approval 
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Quotes used to support 
findings 
Clear clinical and research 
implications 
Christofides 
et al. (2016) 
 
Reflected on why some 
potential participants declined 
to take part 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Clear description of thematic 
analysis process 
Data analysed by more than 
one researcher 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
 
No evidence of having 
involved children in design or 
conduct of the study 
Data saturation not discussed 
No evidence of researcher 
reflexivity 
 
 
Dashiff et al. 
(2013) 
 
Sample clearly described 
Used appropriate methods for 
helping children express their 
views 
Some use of quotes to support 
findings 
Data analysed by more than 
one researcher 
 
 
 
No evidence of having 
involved children in design or 
conduct of the study 
Description of 'qualitative 
description’ limited and 
unclear 
Unclear whether sufficient 
data to support findings 
Data saturation not discussed 
No evidence of researcher 
reflexivity 
 
D'Auria et 
al. (1997) 
 
Researcher not associated with 
clinical team 
Clear description of grounded 
theory process 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Discussed data saturation 
Data analysed by more than 
one researcher 
Quotes used to support 
findings 
 
No evidence of having 
involved children in design or 
conduct of the study 
No evidence of researcher 
reflexivity 
No reference to ethical 
approval 
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Clear discussion of 
implications 
 
Durst et al. 
(2001)  
 
 
Sample clearly described 
Used appropriate methods for 
helping children express their 
views 
Some use of quotes to support 
findings 
 
 
No evidence of having 
involved children in design or 
conduct of the study 
Study design and method 
unclear, mentions ethnography 
in abstract but this is not 
elaborated on in the methods 
section, in main body study 
described as 'descriptive' 
Unclear how the data from 
interviews was collected - no 
mention of audio recording 
No evidence of researcher 
reflexivity 
No reference to ethical 
approval 
 
Foster et al. 
(2001) 
 
 
Researcher not associated with 
clinical team 
Clear description of grounded 
theory process 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Data analysed by more than 
one researcher 
Quotes used to support 
findings 
Discussion of implications 
 
 
No evidence of having 
involved children in design or 
conduct of the study 
No evidence of researcher 
reflexivity 
Data saturation not discussed 
 
Moola & 
Faulkner 
(2014) 
 
 
Some use of quotations to 
support findings 
Implications discussed 
 
No evidence of having 
involved children in design or 
conduct of the study 
Sampling strategy unclear 
(case series described 2 of the 
6 participants) 
Data analysis process unclear - 
thematic analysis mentioned 
but unclear how themes were 
deceived 
Unclear if appropriate methods 
were used to ensure data 
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analysis was grounded in the 
views of children 
No evidence of researcher 
reflexivity 
 
Moola et al. 
(2012) 
Researcher not associated with 
clinical team 
Clear description of grounded 
theory process 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Evidence of researcher 
reflexivity 
Discussed data saturation 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
 
No evidence of having 
involved children in design or 
conduct of the study 
 
Nuttall & 
Nicholes 
(1992) 
 
Clear description of content 
analysis process 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Inter-rater reliability reported 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
No evidence of having 
involved children in design or 
conduct of the study 
No evidence of researcher 
reflexivity 
 
Pizzignacco 
& de Lima 
(2006)  
 
 
Used appropriate methods for 
helping children express their 
views 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
 
No evidence of having 
involved children in design or 
conduct of the study 
Data analysis process unclear - 
thematic analysis mentioned 
but unclear how themes were 
deceived 
No evidence of researcher 
reflexivity 
 
Savage & 
Callery 
(2007) 
Clear description of discourse 
analysis process 
No evidence of having 
involved children in design or 
conduct of the study 
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Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Triangulation of data 
(interviews & observations of 
consultations) 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
No evidence of researcher 
reflexivity 
 
Sawicki et 
al. (2015) 
Used appropriate methods for 
helping children express their 
views 
Some evidence of researcher 
reflexivity 
Discussed inter-rater reliability 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
No evidence of having 
involved children in design or 
conduct of the study 
Unclear which qualitative data 
analysis method was used 
Williams et 
al. (2007a) 
Evidence of having involved 
children in design/conduct of 
the study 
Clear description of framework 
analysis process 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Data analysed by more than 
one researcher 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
Limited evidence of researcher 
reflexivity 
Williams et 
al. (2007b) 
 
Evidence of having involved 
children in design/conduct of 
the study 
Clear description of framework 
analysis process 
Used appropriate methods for 
helping children express their 
views and ensuring data 
Limited evidence of researcher 
reflexivity 
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analysis grounded in the views 
of children 
Data analysed by more than 
one researcher 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
Williams et 
al. (2009) 
UK 
Evidence of having involved 
children in design/conduct of 
the study 
Clear description of framework 
analysis process 
Evidence of researcher 
reflexivity 
Used appropriate methods for 
helping children express their 
views and ensuring data 
analysis grounded in the views 
of children 
Data analysed by more than 
one researcher 
Quotes used to support 
findings 
Clear discussion of 
implications 
 
 
 
Appendix D. Overview of  quality assessment ratings according to CASP and Thomas et al. (2003) criteria 
 
Authors, Year Title 1 2 3 4 5 6 7 8 9 10 11 12 13 
Ayers et al., 2011  Understanding needle-related distress 
in children with cystic fibrosis. 
Y Y Y Y Y ? Y Y Y Y Y Y N 
Barker et al., 2012  Supporting cystic fibrosis disease 
management during adolescence: the 
role of family and friends. 
Y Y Y ? Y ? Y Y Y Y Y Y N 
Christian & 
D'Auria 1997  
The Child's Eye: Memories of 
growing up with cystic fibrosis 
Y Y Y Y Y ? ? Y Y Y Y Y N 
Christofides et al., 
2016  
Heuristic decision-making about 
research participation in children with 
cystic fibrosis. 
Y Y Y Y Y ? Y Y Y Y Y Y N 
Dashiff et al, 2013  Cystic fibrosis-related diabetes in 
older adolescents: Parental support 
and self-management.  
Y Y Y Y Y ? Y ? Y Y Y ? N 
D'Auria et al., 1997  Through the looking glass: children's 
perceptions of growing up with cystic 
fibrosis. 
Y Y Y Y Y ? Y Y Y Y Y Y N 
Durst et al., 2001  Psychosocial responses of adolescent 
cystic fibrosis patients to lung 
transplantation. 
Y Y ? Y ? ? ? ? ? Y Y ? N 
Foster et al., 2001  Treatment demands and differential 
treatment of patients with cystic 
fibrosis and their siblings: Patient, 
parent and sibling accounts. 
Y Y Y Y Y ? Y Y Y Y Y Y N 
Moola & Faulkner 
2014  
'A tale of two cases:' the health, 
illness, and physical activity stories of 
Y Y Y N Y ? ? ? ? Y Y ? N 
two children living with cystic 
fibrosis. 
Moola et al., 2012  No time to play: Perceptions toward 
physical activity in youth with cystic 
fibrosis. 
Y Y Y Y Y Y Y Y Y Y Y Y N 
Nuttall & Nicholes 
1992 
Cystic fibrosis: Adolescent and 
maternal concerns about hospital and 
home care. 
Y Y Y Y Y ? Y Y Y Y Y Y N 
Pizzignacco & de 
Lima 2006  
Socialization of children and 
adolescents with cystic fibrosis: 
Support for nursing care. 
Y Y Y Y Y ? Y ? Y Y Y Y N 
Savage & Callery 
2007  
Clinic consultations with children and 
parents on the dietary management of 
cystic fibrosis. 
Y Y Y Y Y ? Y Y Y Y Y Y N 
Sawicki et al., 2015  Motivating adherence among 
adolescents with cystic fibrosis: 
Youth and parent perspectives 
Y Y Y Y Y Y Y Y Y Y Y Y N 
Williams et al., 
2007a  
From child to adult: An exploration of 
shifting family roles and 
responsibilities in managing 
physiotherapy for cystic fibrosis 
Y Y Y Y Y ? Y Y Y Y Y Y Y 
Williams et al., 
2007b  
Problems and solutions: Accounts by 
parents and children of adhering to 
chest physiotherapy for cystic fibrosis 
Y Y Y Y Y ? Y Y Y Y Y Y Y 
Williams et al., 
2009  
I've never not had it so I don't really 
know what it's like not to: 
Nondifference and biographical 
disruption among children and young 
people with cystic fibrosis. 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
 
CASP Qualitative checklist 
1. Clear statement of aims? 
2. Qualitative methodology appropriate? 
2. 3. Was the research design appropriate to address the aims of the research? 
3. 4. Was the recruitment strategy appropriate? 
4. 5. Was data collected in a way that addressed the research issue? 
5. 6. Has the relationship between researcher & participants been adequately considered? 
6. 7. Have ethics been considered? 
7. 8. Was data analysis sufficiently rigorous? 
8. 9. Is there a clear statement of findings? 
9. 10. How valuable is the research? Thomas et al.  2003 
10. 11. Used appropriate data collection methods for helping children to express their views? 
11. 12. Used appropriate methods for ensuring the data analysis was grounded in the views of children? 
12. 13. Actively involved children in the design and conduct of the study? 
Y = Yes 
N = No 
? = Don’t know 
Appendix E. Theoretical sampling flow chart 
Ethics/R&D approval 
 
Aimed to initially recruit CYP 
 
Initial recruitment difficult (CF clinics run quarterly, summer holidays) 
 
Applied for ethics amendment to allow recruitment via social media/charities 
 
Recruited clinicians x2 (different disciplines). Example initial codes: having a 
team, dealing with difference, change over time, making room for mistakes. 
Main question for next interviews: what is important to the CYP? 
 
1st CYP (male, nearing transfer to adult services, relatively less impacted by CF). 
Example new codes: other people’s assumptions, learning from experience. 
Main question for next interviews: how might this be different for CYP severely 
affected by CF? 
 
2nd CYP (female, ++ CF co-morbidities, missed a lot of school). Example new 
codes: practical problem solving, dealing with difference. Main question for next 
interviews: how might this be different for CYP with less positive relationships 
with the medical team? 
 
3rd CYP (female, more turbulent relationship with medical team, linked in with 
CF community internationally). Example new codes: being informed, 
‘normalising’. Main question for next interviews: How do the CYP interact with 
information about CF? 
 
3rd clinician. Example new codes: having a voice, unique individuals. Main 
question for next interviews: what do parents think is important in relation to 
empowerment in CYP? What insights might be offered by families where more 
than one child has CF? 
 
1st parent (more turbulent relationship with medical team). Example new codes: 
taking charge, being able to be a child, achieving in relation to own goals. Main 
questions for next interviews: How might this be different when families have 
very positive relationships with medical team?  
 
2nd parent (2 children with CF). Example new codes: concealing self, difficulties 
fitting it all in, share burden of CF. Main questions for next interviews: under 
what conditions might CYP be more open about CF? 
 
4th CYP (female, very open about CF, some contact with CF community). 
Example new codes: trusting relationships, explaining to others, active 
participation in decision making. Main question for next interviews: How might 
this be different for CYP who’s care is provided by a big general hospital as 
opposed to a children’s hospital? 
 
3rd parent (parent of younger child, recruited from 2nd hospital site). Example 
new codes: none. Main question for next interviews: how might younger male 
CYP experience empowerment?  
 
5th CYP (male, younger, recruited from 2nd hospital site). Example new codes: 
none. Main question for next interviews: what insights could dads offer in 
relation to empowerment in CYP 
 
4th parent (dad, family historically chose to keep CF relatively private). Example 
new codes: having adventures, achieving in relation to own goals. Main question 
for next interviews: What insights could parents of children who are not 
currently ‘thriving alongside CF’? 
 
5th parent (parent of younger child who is not ‘thriving with CF’, child chose not 
to be interviewed themselves): Example new codes: concealing self, unheard 
voices. Main question for next interviews: Can CYP ‘thrive alongside CF’ whilst 
keeping CF private in some contexts? 
 
6th CYP (recruited from 2nd hospital site, chooses to keep CF relatively private at 
school, would like to find a way of having contact with other CYP with CF). 
Example new codes: none. Main questions for next interview: what insights 
might a clinician with many years’ experience offer? 
 
4th clinician ( ≥ 20 years’ experience). Example new codes: none. Main question 
for next interview:  
 
7th CYP (male, middle of age range, open about CF): none 
 
 
 
Appendix F. Email to CF teams 
 
My name is Naomi Fairweather and I am a trainee clinical psychologist at Canterbury Christ 
Church University.  
 
I am currently working on my doctoral research project, exploring empowerment in children 
and young people with CF during times of change. The findings of this research will inform 
clinical practice. 
 
I am interested in talking to children and young people aged 11-19 years living with CF, their 
parents, and clinical staff. Interviews will last up to one hour and will take place at 
[Children’s Hospital] or via Skype/phone if preferred. I’m aiming to recruit a total of 3-5 
members of staff (ideally from a range of  professional backgrounds) from [Trust] and 
[Trust]. I can be flexible around days and times for interviews which will be taking place 
between now and December. 
 
If you are interested in taking part or have any questions about the research please get in 
touch: n.h.fairweather323@canterbury.ac.uk  
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Research Information Leaflet: Children and Young People 
Empowerment of children and young people living with 
cystic fibrosis during times of change 
Hello. My name is Naomi Fairweather and I am a trainee clinical psychologist at 
Canterbury Christ Church University. I would like to invite you to take part in a 
research study. Before you decide it is important to understand why the research 
is being done and what it involves for you. If you decide to take part please keep 
this information sheet so that you can look at it again if you want to. 
What is this study for?  
We know that many children and young people with medical conditions want 
to feel confident and in control of their lives, but can face barriers. 
Empowering (giving power to) people with medical conditions might mean 
they can stay happier and healthier. I want to know more about the 
empowerment of children and young people with cystic fibrosis (CF).  
Why have I been invited?  
I am interested in talking to children and young people 
aged 11-19 years living with CF during times of change 
like moving schools, becoming more independent at home, making new 
friends and having relationships, and moving on to the adult CF team. 
I also want to speak with parents and medical staff. You have been invited to 
take part because you are within an age range where lots of important life 
changes happen and are under the care of a CF team in the UK.  
Do I have to take part? 
It is up to you to decide whether or not to join the study. You don’t have to 
take part – even if your parents tell you they want you to. If you agree to take part, I will ask you to 
sign a consent form. If you are under 16 years, we will need your parents to agree and sign a form 
first. You are free to change your mind at any time, without giving a reason. This would not affect 
the care you receive in any way. 
What will happen to me if I take part? 
Some information about your CF-related health will be collected from a database. You will be 
invited to take part in an interview so that I can ask you some questions about CF and feeling 
confident in different situations like home, school, and the hospital. Interviews can take place at 
_________________________ Hospital, by phone or using Skype, whichever you prefer. The 
interview will last under an hour. You don’t have to answer all the questions. 
If you choose to have the interview by phone or Skype, I won't be able 
to make sure that no one can hear what you are saying where you are, 
but I will talk to your parents/guardians about how important it is that 
your interview is private. I will make sure no one can overhear our 
conversation where I am. 
Some people might be invited to a second interview and asked extra 
questions – it will be up to you whether you want to or not. 
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Expenses and payments 
I can give you or your parents up to £10 towards travel costs. 
What are the possible benefits of taking part? 
Many people like to know that they have helped with research which might help children and 
young people with CF in the future. We hope this research will help us to better support children 
and young people with CF. 
What are the possible disadvantages and risks of taking part? 
Sometimes talking about your experiences can be upsetting. I am trained to talk to both children 
and adults and to help if someone becomes upset. I can also tell you about other people that 
might be able to help, for example the Cystic Fibrosis Trust. You can contact them via their 
website www.cysticfibrosis.org.uk or call their helpline on 0300 373 1000 or 020 3795 2184. 
 
What will happen to the information given by me? 
All information about you will be kept confidential (private) within the research team. There are two 
situations where I would not be able to keep information private. 
1) If I thought you were at risk of harm 
2) If I thought someone else was at risk of harm 
If this is the case I would always try to talk to you first. 
The interview will be audio-recorded. and the recording will be 
stored safely so that no-one else can listen. I write a report based on 
yours and other people’s answers - no-one will know who you are. 
I will tell your medical team that you are taking part but I won’t let 
them know what you have said. You can talk to anyone you want to 
about the research. 
What if there is a problem? 
I don’t want anything about the research to be upsetting. If you are 
unhappy about anything to do with the research you can talk to me or your 
CF team. You can also choose to drop out of the research at any time and 
you don’t have to so why. I can also tell you about other people who might 
be able to help if you are upset. If you do get upset, I will tell your CF team 
so that they can support you. 
If you have a complaint I will do my best to put it right (there is a phone number and email address 
at the end of this information sheet) or you can talk to the CF team. If you are still unhappy or don’t 
want to talk to me about it, you can talk to Professor Paul Camic, who is in charge of research at 
my university – paul.camic@canterbury.ac.uk, tel:_________________.  There is also an NHS 
Complaints Procedure, you can ask anyone in the CF clinic about this. 
What will happen to the results of the research study? 
At the end of the research a short summary will be available for 
anybody who wants it who has taken part. I will write a report for 
my university course and will let other people know about the 
findings. No-one will be able to tell who the people who took part 
in the research are. 
Appendix G. Child information sheet  
[Trust logo] Version 2.0 14.04.18 IRAS Ref Number: 234289 
 
3 
Who is organising and funding the research? 
This project is funded by Canterbury Christ Church University. In the research team, as well as 
me, are Dr Fergal Jones, Dr Sally Clarke and Dr Martha Deiros Collado. They are all clinical 
psychologists who are helping me to do the study. I may also ask someone to type out what you 
have said to me. They will sign a form promising to keep your information private. 
Who has reviewed the study?  
All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee, to make sure it is safe and fair. This study has been looked at by ______________ 
Research Ethics Committee.  
What happens now? 
If you would like to help us by taking part in this research, you or your 
parents can contact me directly (phone number and email address at 
the end of this information sheet), or you can let me know when I 
contact you in a couple of weeks’ time. We will need to arrange a time 
to meet at ________________ Hospital and will try and make it before 
or after a clinic appointment so you don’t have to travel especially to 
see me. Alternatively we could do the interview on the phone or 
Skype. I will explain the study and answer any questions you might 
have.  
I will ask everyone who wants to take part to sign a form to say that they understand what the 
research is about and are willing to be involved. If you are under 16, legally I also need your 
parent/guardian to sign a form to say they agree to you taking part. 
Further information and contact details 
If… 
• you would like to help us by taking part in this research 
• you would like information about the research 
• you would like to know more about this study 
please contact: 
Naomi Fairweather 
Trainee Clinical Psychologist 
Salomons Centre for Applied Psychology, 
Canterbury Christ Church University 
Email: N.H.Fairweather323@canterbury.ac.uk 
Telephone: You can leave a message for me on a 24-hour voicemail phone line at 03330117070. 
Please say that the message is for Naomi Fairweather and leave a contact number so that I can 
get back to you. 
Thank you for reading about my study. I will contact you by phone within two weeks if I 
have not heard from you, to see if you want to take part. 
 
Appendix H. Young person information sheet  
[Trust logo] Version 2.0 14.04.18 IRAS Ref Number: 234289  
 
1 
 
Research Information Leaflet: Young people 
Empowerment of children and young people living with cystic fibrosis 
during times of change 
 
 
Hello. My name is Naomi Fairweather and I am a trainee clinical psychologist 
at Canterbury Christ Church University. I would like to invite you to take part 
in a research study. Before you decide it is important that you understand 
why the research is being done and what it would involve for you. If you 
decide to take part please keep this information sheet so that you can look at 
it again if you want to. 
 
What is this study for?  
We know that many children and young people with medical conditions want to feel confident and 
in control of their lives, but can face barriers. Empowering people with medical conditions might 
mean they can stay happier and healthier. I want to know more about the empowerment of 
children and young people with cystic fibrosis (CF).  
 
Why have I been invited?  
 
I am interested in talking to children and young people aged 11-19 years living with CF during 
times of change like going to college, becoming more independent at home, making new friends 
and having relationships, and moving on to the adult CF team. 
I also want to speak with parents and medical staff. You have been invited to take part because 
you are within an age range where lots of important life changes happen and are under the care of 
a CF team in the UK.  
 
Do I have to take part?  
 
It is up to you to decide whether or not to join the study. If you agree to take part, I will then ask 
you to sign a consent form. If you are under 16 years, we will need your parents to agree and sign 
a form first. You are free to change your mind at any time, without giving a reason. This would not 
affect the care you receive in any way. 
 
What will happen to me if I take part?  
 
Some information about your CF-related health will be collected from a database.  You will be 
invited to take part in an interview so that I can ask you some questions about CF and feeling 
confident in different situations like home, school or college, and the hospital. Interviews can take 
place at _________________________ Hospital, by phone or using Skype, whichever you prefer. 
The interview will last under an hour. You don’t have to answer all the questions. 
 
If you choose to have the interview by phone or Skype, I won't be able to make sure that no one 
can hear what you are saying where you are, but I can talk to your parents/guardians about how 
important it is that your interview is private if you want me to. I will make sure no one can overhear 
our conversations where I am. 
Some people might be invited to a second interview and asked extra questions – it will be up to 
you whether you want to or not. 
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Expenses and payments   
 
I can give people who take part up to £10 towards travel costs. 
 
What are the possible benefits of taking part?   
 
Many people like to know that they have helped with research which might help children and 
young people with CF in the future. We hope this research will help us to better support children 
and young people with CF. 
 
What are the possible disadvantages and risks of taking part?  
 
Sometimes talking about your experiences can be upsetting. I am trained to talk to children, young 
people and adults, and to help if someone becomes upset. I can also tell you about other people 
that might be able to help, for example the Cystic Fibrosis Trust. You can contact them via their 
website www.cysticfibrosis.org.uk or call their helpline on 0300 373 1000 or 020 3795 2184. 
 
What will happen to the information given by me? 
 
All information which is collected from you during the research will be kept strictly confidential, and 
any information which leaves ________________ hospital will have names removed so that you 
cannot be recognised. There are only two occasions when I might need to break confidentiality, 
this would be if you were to say something that made me worry that you or someone else may be 
at risk. I would normally talk to you first before breaking confidentially in this situation unless I 
thought this would lead to further risk to you.   
 
Interviews will be audio recorded and transcribed, either by the researcher or by a professional 
transcriber who has signed a confidentiality agreement. Once transcribed, the audio recordings 
will be deleted. The interviews will be analysed by the researcher Naomi Fairweather. The only 
other people who will have access to your information are the other members of the research 
team, clinical psychologists Dr Fergal Jones, Dr Sally Clarke and Dr Martha Deiros Collado. 
 
All of the information collected in this study will be stored securely, and all names and personal 
information will be removed to ensure the information is anonymous. Personal details that 
have been collected for the purposes of making contact with you and arranging an appointment to 
meet will be kept separately and securely, and will be destroyed at the end of the study. All 
information collected in interview will be kept in a password protected file at Canterbury Christ 
Church University, at _________________________ hospital and with me (Naomi Fairweather) 
for 5 years. 
 
Your medical consultant will be informed that you are participating in the research but will not be 
given access to any audio recordings or transcripts. You are welcome to discuss this research with 
whoever you want, including friends, family, the doctor or clinical nurse specialist. 
 
What if there is a problem?  
 
I don’t want anything about the research to be upsetting.  If you are unhappy about anything to do 
with the research you can talk to me or a doctor or a nurse. You can also choose to drop out of the 
research at any time and you don’t have to so why. I can also tell you about other people who 
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might be able to help if you are upset. If you do get upset, I will tell your CF team so that they can 
support you. 
If you have a complaint you should ask to speak to me and I will do my best to put it right (there is 
a phone number and email address at the end of this information sheet). If you are still unhappy or 
don’t want to talk to me about it, you can talk to Professor Paul Camic, who is in charge of 
research at my university – paul.camic@canterbury.ac.uk, tel:_________________.   There is also 
an NHS Complaints Procedure, you can ask anyone in the CF clinic about this. 
 
What will happen to the results of the research study?  
 
At the end of the research a short outline of the findings will be available for participants on 
request. Findings will be written up as part of a doctorate research project and it is hoped that 
results will be published in a professional journal. In the initial write up and any subsequent 
publications anonymised quotes from interviews will be used but care will be taken to make sure 
that participants are not identifiable. 
 
Who is organising and funding the research? 
 
This project is funded by Canterbury Christ Church University. 
 
Who has reviewed the study?  
 
All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee, to make sure it is safe and fair. This study has been looked at by ______________  
Research Ethics Committee.  
 
What happens now? 
 
If you would like to help us by taking part in this research, you can contact me directly or you can 
let me know when I contact you in a couple of weeks’ time. We will need to arrange a time to meet 
at ________________ hospital and will try to combine this with your usual clinic appointment. 
Alternatively we can arrange for the interview to be conducted via phone or videoconferencing app 
such as Skype. I will explain the study and answer any questions you  might have.  
 
Further information and contact details 
 
If….. 
• You would like to help us by taking part in this research 
• You would like information about the research or like to know more about this study 
 
Please contact: 
 
Naomi Fairweather 
Trainee Clinical Psychologist, 
Salomons, Canterbury Christ Church University 
Email: N.H.Fairweather323@canterbury.ac.uk 
Telephone:  You can leave a message for me on a 24-hour voicemail phone line at 03330117070. 
Please say that the message is for me, Naomi Fairweather and leave a contact number so that I 
can get back to you. 
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Thank you for reading about my study. I will contact you by phone within two weeks if I have not 
heard from you, to see if you want to take part. 
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Research Information Leaflet: Parents 
Empowerment of children and young people living with cystic fibrosis 
during times of change 
 
 
Hello. My name is Naomi Fairweather and I am a trainee clinical psychologist at 
Canterbury Christ Church University. I would like to invite you and/or your child 
to take part in a research study. Before you decide it is important that you 
understand why the research is being done and what it would involve. If you 
decide to take part please keep this information sheet for reference. 
 
 
What is the purpose of the study?  
We know that many children and young people with medical conditions want to feel confident and 
in control of their lives, but can face barriers. Empowering people with medical conditions has the 
potential to impact significantly on long term health and social outcomes. Much of what is known 
about patient empowerment focuses on adults. To the author’s knowledge there is no research 
(with adults or children) looking specifically at cystic fibrosis (CF) and empowerment.  
Why have I been invited?  
 
I am interested in talking to children and young people aged 11-19 years living with CF, their 
parents, and staff. I want to ask some questions about living with CF during time of change, like 
starting a new school or college, becoming more independent at home, making new friends and 
having relationships, and moving to the adult CF team. 
You and your child have been invited to take part because your child falls within an age range 
where lots of important changes happen and is under the care of a CF team in the UK. There is a 
separate information sheet for children and young people, but they may wish to read this one too.  
We don’t need all members of a family to take part. Some children might not want to even if their 
parent(s) chooses to. Some parents might not want to even if their child chooses to. 
This information sheet applies if you are thinking about participating yourself, or if you are deciding 
whether or not to give consent for your child to participate. If your child is under 16 years old you 
will need to sign a consent form to say that you agree to them taking part. Even if you consent to 
their participation, they will only be eligible to participate if they want to. 
Do I have to take part?  
 
It is up to you (and your child) to decide whether or not to join the study. If you agree to take part, I 
will then ask you to sign a consent form. You are free to withdraw at any time, without giving a 
reason. This would not affect the care you or your child receive in any way. 
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What will happen to me if I take part?  
 
If you decide to take part, I will meet with you (and/or your child) for an interview to ask some 
questions about CF and empowerment. Some information about your child’s CF-related health will 
be collected from a database. I will be asking questions to children, parents, and staff in separate 
interviews. Interviews will take place at _________________________ Hospital or via telephone 
or Skype if preferred, at a time which is convenient for you. All interviews will last under an hour. I 
will be asking some questions about children and young people with CF and confidence in 
different situations like at home, school or college, and the hospital. No one will have to talk about 
anything they feel uncomfortable talking about.  
If you or your child choose to be interviewed by phone or Skype, it is important to note that the 
researcher will not be able to guarantee that you/your child will not be overheard where you are. It 
is important that participants have privacy for their interview. If your child is being interviewed by 
phone or Skype, please try to ensure that no one can overhear them. 
Some people might be invited to a second interview and asked extra questions – it will be up to 
you whether you want to or not. 
 
Expenses and payments   
 
I can reimburse travel costs of up to £10 per participant. 
 
What are the possible benefits of taking part?   
 
Many people like to know that they have helped with research which might help children and 
young people with CF in the future. We hope this research will help us to better support children 
and young people with CF. 
 
What are the possible disadvantages and risks of taking part?  
 
Sometimes talking about your experiences can be upsetting. I am trained to talk to children, young 
people and adults, and to help if someone becomes upset. I can also tell you about other people 
that might be able to help, for example the Cystic Fibrosis Trust. You can contact them via their 
website www.cysticfibrosis.org.uk or call their helpline on 0300 373 1000 or 020 3795 2184. 
 
What will happen to the information given by me and/or my child? 
 
All information which is collected from you or your child during the research will be kept strictly 
confidential, and any information which leaves ________________ hospital will have names 
removed so that you cannot be recognised. There are only two occasions when I might need to 
break confidentiality, this would be if you or your child were to say something that made me worry 
that you or someone else may be at risk. I would normally talk to you and/or your child first before 
breaking confidentially in this situation unless I thought this would lead to further risk to you/your 
child. 
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Interviews will be audio recorded and transcribed, either by the researcher or by a professional 
transcriber who has signed a confidentiality agreement. Once transcribed, the audio recordings 
will be deleted. The interviews will be analysed by the researcher, Naomi Fairweather. All 
participants will be given the opportunity to check the accuracy of data held about them and 
correct any errors. The only other people who will have access to your information/your child’s 
information are the other members of the research team, clinical psychologists Dr Fergal Jones, 
Dr Sally Clarke and Dr Martha Deiros Collado. 
 
All of the information collected in this study will be stored securely, and all names and personal 
information will be removed to insure the information is anonymous. Personal details that 
have been collected for the purposes of making contact with you and arranging an appointment to 
meet will be kept separately and securely, and will be destroyed at the end of the study. All 
information collected in interview will be kept in a password protected file at Canterbury Christ 
Church University, at _________________________ hospital and with me (Naomi Fairweather) 
for 5 years. 
 
Your child’s medical consultant will be informed that you and/or your child is participating in the 
research but will not be given access to any audio recordings or transcripts. You and your child 
are welcome to discuss this research with whoever you want, including friends, family, the doctor 
or clinical nurse specialist. 
 
 
 
What if there is a problem?  
 
The questions are not intended to cause distress and we do not expect that your child will have 
any problems taking part. However, if your child is unhappy about anything relating to the study 
they can talk to their doctor or nurse. They also have the choice to withdraw from the study at any 
time of they want to.  
 
Any complaint about the way that you or your child have been dealt with during the study or any 
concerns about possible harm they might suffer will be addressed. If you have a concern about 
any aspect of this study, you should ask to speak to me and I will do my best to address your 
concerns (see contact details at the end of this information sheet). If you remain unhappy and wish 
to complain formally, you can do this by contacting Professor Paul Camic, Research Director, 
Salomons Centre for Applied Psychology – paul.camic@canterbury.ac.uk, 
tel:_________________.   If you remain unhappy and wish to complain formally, you can do this 
through the NHS Complaints Procedure. Details can be obtained from the CF clinic 
 
 
What will happen to the results of the research study?  
 
At the end of the research a short outline of the findings will be available for participants on 
request. Findings will be written up as part of a doctorate research project and it is hoped that 
results will be published in a professional journal. In the initial write up and any subsequent 
publications anonymised quotes from interviews will be used but care will be taken to make sure 
that participants are not identifiable. 
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Who is organising and funding the research? 
 
This project is funded by Canterbury Christ Church University. 
 
 
Who has reviewed the study?  
 
All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee, to protect your interests and those of your child. This study has been reviewed and 
given favourable opinion by ______________  Research Ethics Committee.  
 
 
What happens now? 
 
If you and/or your child would like to help us by taking part in this research, they, or you, can 
contact me directly or you can let me know when I contact you in a couple of weeks’ time. We can 
arrange a time to meet at ________________ hospital and will try to combine this with your child’s 
usual clinic appointment. Alternatively we can arrange for the interview(s) to be conducted via 
phone or Skype. I will explain the study and answer any questions you or your child might have.  
 
I will ask all parents taking part to sign a consent form for themselves. If your child is 16 years old 
or over they are legally able to consent to participate and I will ask them to sign a consent form. If 
they are under the age of 16 years we will require your agreement for them to participate and I will 
ask you to sign a consent form on their behalf, and ask your child to sign an assent form. 
 
Further information and contact details 
 
If….. 
• You and/or your child would like to help us by taking part in this research 
• You would like information about the research or like to know more about this study 
 
Please contact: 
 
Naomi Fairweather 
Trainee Clinical Psychologist, 
Salomons, Canterbury Christ Church University 
Email: N.H.Fairweather323@canterbury.ac.uk 
Telephone:  You can leave a message for me on a 24-hour voicemail phone line at 03330117070. 
Please say that the message is for me Naomi Fairweather and leave a contact number so that I 
can get back to you. 
 
Thank you for reading about my study. I will contact you by phone within two weeks if I have not 
heard from you, to see if you and/or your child want to take part. 
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Research Information Leaflet: Staff 
Empowerment of children and young people living with cystic fibrosis 
during times of change 
My name is Naomi Fairweather and I am a trainee clinical psychologist at 
Canterbury Christ Church University. I am contacting you to invite you to 
participate in my doctoral research study. Please retain this information sheet for 
your reference. 
 
What is the purpose of the study?  
Previous research has shown that many children and young people with medical 
conditions want to feel confident and in control of their lives, but can face barriers. Empowering 
people with medical conditions has the potential to impact significantly on long term health and 
social outcomes. Much of what is known about patient empowerment focuses on adults. To the 
author’s knowledge there is no research (with adults or children) looking specifically at cystic 
fibrosis (CF) and empowerment. 
Why have I been invited?  
 
I am interested in talking to children and young people aged 11-19 years living with CF, their 
parents, and clinicians. You have been invited to take part because you work within a CF team in 
the UK. There are separate information sheets for children and young people, and parents. 
Do I have to take part?  
 
It is up to you to decide whether or not to join the study. If you agree to take part, I will then ask 
you to sign a consent form. You are free to withdraw at any time, without giving a reason. 
 
What will happen to me if I take part?  
 
If you decide to take part, I will meet with you for an interview to ask some questions about CF and 
empowerment. I will be asking questions to children, parents, and staff in separate interviews. 
Interviews will take place at _________________________ Hospital or via telephone or Skype if 
preferred, at a time which is convenient for you. All interviews will last under an hour. I will be 
asking some questions about children and young people with CF and confidence in different 
situations like at home, school or college, and the hospital. No one will have to talk about anything 
they feel uncomfortable talking about. 
If you choose to be interviewed remotely, e.g. via telephone, the researcher cannot guarantee 
privacy at your location, but will ensure the interview cannot be overheard at the researcher’s 
location. 
You may be invited to a second interview. Consent to participating in this additional interview will 
be sought following the initial interview if applicable, and will not be assumed. You can withdraw 
from the study at any time. 
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Expenses and payments 
I can reimburse travel costs of up to £10 per participant. 
 
What are the possible benefits of taking part? 
There are no direct personal benefits to taking part in this study, but participants may help to make 
a contribution to the research evidence in this area. 
 
What are the possible disadvantages and risks of taking part? 
Discussing your clinical experience of working with children and young people with CF and their 
families may be distressing. I am trained to talk to children, young people and adults, and to help if 
someone becomes distressed. I have experience of conducting research involving healthcare 
professionals. I can also signpost to other sources of support.  
What will happen to the information given by? 
 
All information which is collected from you during the research will be kept strictly confidential, and 
any information which leaves ________________ hospital will have names removed so that you 
cannot be recognised. There are only two occasions when I might need to break confidentiality, 
this would be if you were to say something that made me worry that you or someone else may be 
at risk. I would normally talk to you first before breaking confidentially in this situation unless I 
thought this would lead to further risk to you/other people.   
 
Interviews will be audio recorded and transcribed, either by the researcher or by a professional 
transcriber who has signed a confidentiality agreement. Once transcribed, the audio recordings 
will be deleted. The interviews will be analysed by the researcher, Naomi Fairweather. Other 
members of the research team who will have access to the data are clinical psychologists Dr 
Fergal Jones, Dr Sally Clarke and Dr Martha Deiros Collado. 
 
All of the information collected in this study will be stored securely, and all names and personal 
information will be removed to ensure the information is anonymous. Personal details that 
have been collected for the purposes of making contact with you and arranging an appointment to 
meet will be kept separately and securely, and will be destroyed at the end of the study. All 
information collected in interview will be kept in a password protected file at Canterbury Christ 
Church University, at _________________________ hospital and with me (Naomi Fairweather) 
for 5 years. 
 
You are welcome to discuss this research with whoever you want, including friends, family and 
colleagues. 
 
What if there is a problem?  
 
The questions are not intended to cause distress and we do not expect that you will have any 
problems taking part. However, if you are unhappy about anything relating to the study you can 
raise this with me or my university. 
 
Any complaint about the way that you have been dealt with during the study or any concerns 
about possible harm anyone taking part might suffer will be addressed. If you have a concern 
about any aspect of this study, you should ask to speak to me and I will do my best to address 
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your concerns (see contact details at the end of this information sheet). If you remain unhappy and 
wish to complain formally, you can do this by contacting Professor Paul Camic, Research Director, 
Salomons Centre for Applied Psychology – paul.camic@canterbury.ac.uk, 
tel:_________________.   If you remain unhappy and wish to complain formally, you can do this 
through the NHS Complaints Procedure. 
 
What will happen to the results of the research study?  
 
At the end of the research a short outline of the findings will be available for participants on 
request. Findings will be written up as part of a doctorate research project and it is hoped that 
results will be published in a professional journal. In the initial write up and any subsequent 
publications anonymised quotes from interviews will be used but care will be taken to make sure 
that participants are not identifiable. 
 
Who is organising and funding the research? 
 
This project is funded by Canterbury Christ Church University. 
 
Who has reviewed the study?  
 
All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee, to protect your interests and those of your child. This study has been reviewed and 
given favourable opinion by ______________  Research Ethics Committee.  
 
What happens now? 
 
If you would like to help us by taking part in this research you, can contact me directly or you can 
let me know when I contact you in a couple of weeks’ time. We will need to arrange a time to meet 
at ________________ hospital. Alternatively we can arrange for the interview to be conducted via 
phone or Skype. I will explain the study and answer any questions you might have. I will ask 
everyone taking part to sign a consent form. 
 
Further information and contact details 
 
If….. 
• You would like to help us by taking part in this research 
• You would like information about the research or like to know more about this study 
Please contact: 
 
Naomi Fairweather 
Trainee Clinical Psychologist, 
Salomons, Canterbury Christ Church University 
Email: N.H.Fairweather323@canterbury.ac.uk 
Telephone:  You can leave a message for me on a 24-hour voicemail phone line at 03330117070. 
Please say that the message is for me (Naomi Fairweather) and leave a contact number so that I 
can get back to you. 
 
Thank you for reading about my study. I will contact you via phone if I have not heard from you 
within two weeks. 
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Form to be on headed paper)  
Centre Number:  
Participant Identification Number for this study:  
ASSENT FORM  
Title of Project: Empowerment of children and young people living with cystic fibrosis 
during times of change 
Name of Researcher: Naomi Fairweather 
If you agree, please put your initials in the boxes 
 
1. Yes, I have read the information sheet 
and understand this. 
 
 
2. Naomi gave me time to think about what 
I read and ask questions about it.  
I am happy with her answers and 
understand these. 
 
 
3. I understand that I am choosing to take 
part in this interview, and I can change 
my mind at any time and don’t need to tell 
Naomi why.  Choosing to take part 
doesn’t affect my treatment or support 
from the service in any way. I might be 
asked to do a second interview but I don’t 
have to say yes. 
  
4. I agree that Naomi can record my 
interview.  I am happy for her to use bits 
of what I say in her work as long as 
nobody could tell that it was me who was 
interviewed.    
 
5. I agree that Naomi can use quotes from 
my interview in any published papers as 
long as I can’t be recognised.   
  
6. I agree to take part in the above study. 
 
 
Name of Participant____________________ Date________________  
Signature ___________________ 
 
 
Name of Researcher taking Assent_________________ Date ________________ 
Signature ____________________ 
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Form to be on headed paper)  
Centre Number:  
Study Number:  
Participant Identification Number for this study:  
 
CONSENT FORM  
Title of Project: Empowerment of children and young people living with cystic fibrosis 
during times of change 
Name of Researcher: Naomi Fairweather 
 
Please initial box  
 
1. I confirm I have read and understand the information sheet dated [date] 
(version 2.0) for the above study. 
 
 
  
2. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
 
  
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, and without my care being 
affected in any way. 
 
 
  
4. I understand that I may be invited to a second interview but can decide not 
to take part. 
 
 
  
5. I agree to my interview being audio-recorded and anonymous quotes 
appearing in academic work. 
 
 
  
6. I agree that anonymous quotes from the interview may be used in 
published reports of the study findings. 
 
 
  
7. I agree to take part in the above study.  
 
Name of Participant______________________________ Date ________________ 
 
Signature ____________________ 
Name of Researcher taking Consent_________________________ Date ________________ 
 
Signature ____________________ 
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Form to be on headed paper)  
Centre Number:  
Study Number:  
Participant Identification Number for this study:  
 
CONSENT FORM  
Title of Project: Empowerment of children and young people living with cystic fibrosis 
during times of change 
Name of Researcher: Naomi Fairweather 
 
Please initial box  
 
1. I confirm I have read and understand the information sheet dated [date] 
(version 2.0) for the above study. 
 
 
  
2. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
 
  
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, and without my child’s 
care being affected in any way. 
 
 
  
4. I understand that I may be invited to a second interview but can decide not 
to take part. 
 
 
  
5. I agree to my interview being audio-recorded and anonymous quotes 
appearing in academic work. 
 
 
  
6. I agree that anonymous quotes from the interview may be used in 
published reports of the study findings. 
 
 
  
7. I agree to take part in the above study.  
 
Name of Participant____________________  
 
Signature ____________________ 
 
Name of Researcher taking Consent_________________ Date ________________ 
 
Signature ____________________ 
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Form to be on headed paper)  
Centre Number:  
Study Number:  
Participant Identification Number for this study:  
 
CONSENT FORM  
Title of Project: Empowerment of children and young people living with cystic fibrosis 
during times of change 
Name of Researcher: Naomi Fairweather 
 
Please initial box  
 
1. I confirm I have read and understand the information sheet dated [date] 
(version 2.0) for the above study. 
 
 
  
2. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
 
  
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, and without my job being 
affected in any way. 
 
 
  
4. I understand that I may be invited to a second interview but can decide not 
to take part. 
 
 
  
5. I agree to my interview being audio-recorded and anonymous quotes 
appearing in academic work. 
 
 
  
6. I agree that anonymous quotes from the interview may be used in 
published reports of the study findings. 
 
 
  
7. I agree to take part in the above study.  
 
Name of Participant____________________  
 
Signature ____________________ 
 
Name of Researcher taking Consent_________________ Date ________________ 
 
Signature ____________________ 
Appendix O. Initial interview schedule child & young people Version 1.0 01.03.18 IRAS Ref 
Number: 234289 
 
 
Child and young people interview schedule 
 
Thank you for taking part in my research. I am interested in finding out how children 
and young people living with CF experience empowerment in different situations (like 
home, school and the clinic/hospital). It is difficult to say exactly what empowerment 
is, some people think that empowerment involves having enough information and 
understanding it, having choices and being in control, and being able to cope with 
difficult situations and feelings – I am interested in any other ideas you might have 
about empowerment. I want to know what helps children and young people feel 
empowered, what gets in the way and what the consequences of empowerment are. 
I want to ask you some questions today about yourself, about CF and about your 
experiences of empowerment at home, at school and at the hospital. If there are any 
questions you do not want to answer that is OK, just let me know. 
• Tell me a little bit about yourself [what sorts of things are you interested in? 
what sorts of things do you like doing?] 
 
• When do you feel most confident? 
 
• What is it like to be a [age] year old with CF? [at home, at school, with friends, 
at the hospital] 
 
• How do you handle change? [what important changes have there been in 
your life so far? What changes do you think will come up in the future?] 
 
• How do you take care of yourself? (What challenges have you had? Can you 
give me an example of a time you’ve handled things really well? What helped 
you do this?) 
 
• What helps you manage CF? [what helps you manage difficult things about 
CF or CF worries?] 
 
• What do you think could be done to help children feel more in charge of CF? 
 
• What do you think about transitioning to the adult CF team? Do you have any 
hopes or fears? 
 
• What hopes or wishes  do you have for your life? 
 
• If you had to give a message to hospital staff wanting to learn about how to 
help children with CF what would it be? [what about friends, teachers, 
parents?] 
 
Appendix O. Initial interview schedule child & young people Version 1.0 01.03.18 IRAS Ref 
Number: 234289 
 
 
We have now reached the end of the interview – do you have any questions for me 
or anything else you would like to say before we finish? Thank you for taking part in 
my study. 
Appendix P. Initial interview schedule parent Version 1.0 01.03.18 IRAS Ref Number: 
234289 
 
 
Parent interview schedule 
 
Thank you for taking part in my research. I am interested in finding out how children 
and young people living with CF experience empowerment during key life transitions. 
I want to find out what helps children and young people feel empowered, what gets 
in the way and what the consequences of empowerment are. I want to ask you some 
questions today about your child, about CF and about your  child’s experiences at 
school, with friends, at home and at the hospital. If there are any questions you do 
not want to answer that is OK, just let me know. 
 
• In what situations is your child most confident? [what is it about those 
situations that means they feel more confident?] 
 
• How much do you think your child knows about CF? (where did they get the 
information? How has this changed over time?) 
 
• How does your child handle change? [what important changes have there 
been in their life so far? What changes do you think will come up in the 
future? What do you think helps them handle change? What gets in the way?] 
 
• How does your child take care of her/himself (What challenges has your child 
had? Can you give me an example of a time when your child handled things 
really well? What helped them do this?) 
 
• What bits of your child’s CF care are they doing? What bits are you/other 
people doing? How has this changed as they have got older? 
 
• What helps your child manage CF related worries? 
 
• What do you think could be done to help children feel more in charge of CF? 
 
• What are your thoughts about your child transitioning to adult services? What 
are your fears? What are your hopes?  
 
• What hopes do you have for your child’s life? 
 
• If you had to give a message to hospital staff wanting to learn about how to 
empower children with CF what would it be? [what about your child’s friends, 
teachers, other parents of children with CF] 
 
 
Appendix P. Initial interview schedule parent Version 1.0 01.03.18 IRAS Ref Number: 
234289 
 
 
We have now reached the end of the interview – do you have any questions for 
me or anything else you would like to say before we finish? Thank you for taking 
part in my study. 
Appendix Q. Initial interview schedule clinician Version 1.0 01.03.18 IRAS Ref Number: 
234289 
 
 
Clinician interview schedule 
 
 
Thank you for taking part in my research. I am interested in finding out how children 
and young people living with CF experience empowerment in different settings. I 
want to find out what helps children and young people feel empowered, what gets in 
the way and what the consequences of empowerment are. I want to ask you some 
questions today about the children and young people you work with, about CF and 
about your perceptions of  children and young peoples’ experiences of 
empowerment at home, at school and in the hospital. If there are any questions you 
do not want to answer that is OK, Just let me know. 
 
• When do you think the children and young people you work with feel most 
confident? [what do you think it is about those situations that helps them feel 
confident?] 
 
• How much do you think the children and young people you work with (aged 
11-19) know about CF? (where did they get the information? How has this 
changed over time?) 
 
• How do you think the children and young people you work with handle 
change? [what important changes do they face? What do you think helps 
them handle change? What gets in the way?] 
 
• Let’s talk about children and young people with CF taking care of themselves 
(What challenges do you think the children and young people you work with 
have? [without giving any identifying details] Can you give me an example of 
a time a child handled things really well? What helped them do this?) 
 
• What bits of CF care do you think children and young people aged 11-19 are 
they doing themselves? What bits are you/other people doing? How does this 
changed as they have got older? 
 
• What helps children and young people aged 11-19 manage CF related 
worries? 
 
• What do you think could be done to help children and young people aged 11-
19 feel more in charge of CF? [at home, with friends, at school, at the 
hospital] 
 
• What hopes do you have for the lives of the children and young people aged 
11-19 that you work with?  
 
Appendix Q. Initial interview schedule clinician Version 1.0 01.03.18 IRAS Ref Number: 
234289 
 
 
• If you had to give one message to other hospital staff wanting to learn about 
how to empower children and young people with CF what would it be? What 
message would you give to parents about how to empower children and 
young people with CF? 
 
We have now reached the end of the interview – do you have any questions for 
me or anything else you would like to say before we finish? Thank you for taking 
part in my study. 
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c:\users\vc37\appdata\local\microsoft\windows\temporary internet files\content.ie5\54c9c5rw\transcribing 
agreement july 2011.doc 
Confidentiality Statement for Persons Undertaking 
Transcription of Research Project Interviews 
 
 
 Project title: Empowerment of children and young people with cystic fibrosis 
during times of change
Researcher’s  name: Naomi Fairweather
 
 
The tape/s or recording/s you are transcribing have been created as part of a 
research project. Tapes may contain information of a very personal nature, 
which should be kept confidential and not disclosed to others. Maintaining 
this confidentiality is of utmost importance to the University. Signing this 
form means you agree not to disclose any information you may hear on the 
recording to others, and not to reveal any identifying names, place-names or 
other information on the recording to any person other than the 
researcher/s named above. You agree to keep the recording in a secure place 
where it cannot be accessed or heard by other people, and to show your 
transcription only to the relevant individual/s who is involved in the research 
project, i.e. the researcher/s named above.  
 
You will also follow any instructions given to you by the researcher about 
how to disguise the names of people and places talked about on any 
redordings as you transcribe them, so that the written transcript will not 
contain such names of people and places. 
 
Following completion of the transcription work you will not retain any 
recordings or transcript material, in any form. You will pass all tapes back to 
the researcher and erase any material remaining on your computer hard 
drive or other electronic medium on which it has been held.  
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You agree that if you find that anyone speaking on a tape is 
known to you, you will stop transcription work on that tape 
immediately and pass it back to the researcher. 
 
Declaration 
I agree that: 
1. I will discuss the content of the recording/s only with the researcher/s 
named on the previous page. 
2. I will keep all recordings in a secure place where they cannot be found or 
heard by others. 
3. I will treat the transcripts of the recordings as confidential information. 
4. I will agree with the researcher how to disguise names of people and 
places on the recordings. 
5. I will not retain any material following completion of transcription. 
6. If the person being interviewed on a recording is known to me I will 
undertake no further transcription work on the recording and will return 
it to the researcher as soon as is possible. 
 
I agree to act according to the above constraints 
Your name   _________________________________ 
Signature  ___________________________________ 
Date        ____________________________________ 
Occasionally, the conversations on recordings can be distressing to hear. If 
you should find it upsetting, please speak to the researcher. 
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Appendix X. Coding table 
As hundreds of open codes were produced, the following table contains examples of from 
each category rather than an exhaustive list. 
 
Selective code Axial codes Open codes 
Having a team Team membership 
 
• Ref to having a team 
• YP ref to role of family 
• Parent ref to role of family 
• Prof ref to role of family 
• Ref to at least one good friend 
• YP ref to role of friends 
• Parent ref to role of friends 
• Prof ref to role of friends 
• Ref to role of medical team 
• Ref to role of school 
• Ref to CF community 
 
Provides a sense of 
acceptance/ 
‘normalising’ 
 
• Parent ref to belonging 
• Prof ref to belonging 
• YP ref to being accepted 
• YP ref to fitting in 
 
Share burden of CF • Ref to sharing responsibility 
• Ref to practical support 
• Ref to emotional support 
• Ref to multiple supportive roles 
 
Makes room for 
mistakes/ learning from 
experience 
 
• Prof describing role as coaching 
• Parent talking about YP learning 
from experience 
• Prof reflecting on role of mistakes 
 
Trusting relationships • YP reflecting on trusting 
relationships 
• Parent ref to trusting relationships 
• Prof ref to trusting relationships 
 
Taking charge 
and ‘having a 
voice’ 
Information and 
understanding 
 
• YP ref to interacting with 
information about CF 
• Parent ref to information and 
understanding 
• Prof ref to information and 
understanding 
• Ref to technology 
 
Active participation in 
decision-making 
 
• YP reflecting on making decisions 
• Parent reflecting on making 
decisions 
• YP reflecting on having a voice 
• Parent highlighting importance of 
YP having a voice 
• Parent ref to YP confidence 
• Prof reflecting on making 
decisions 
 
Explaining to others 
 
• YP reflecting on explaining to 
others 
• YP reflecting on sharing personal 
information 
• YP ref to raising awareness 
• Parent reflecting on YP explaining 
to others 
• Prof ref to YP explaining to others 
 
‘Finding ways round and 
through’/ practical 
problem solving 
 
• YP reflecting on asking for help 
• YP describing coping strategies 
• YP describing ways around 
limitations 
• Parent describing YP’s coping 
strategies 
• Parent ref to YP facing challenges 
• YP making the most of things 
• YP ref to routine 
• YP talking about the importance of 
hope 
• Ref to preparing for future 
 
Thriving 
alongside CF 
Being able to just be a 
child/getting on with life 
 
• YP talking about who they are 
• YP ref to non-CF challenges 
• Parent ref to child’s life being 
more than CF 
• Prof hopes for the future of YP 
they support 
• Ref to priorities 
 
Self-acceptance/dealing 
with difference 
 
• Ref to dealing with difference 
• YP expressing acceptance 
• YP reflecting on developing 
confidence 
• YP sharing stories of survival 
• YP showing wisdom 
 
Achieving in relation to 
own goals 
 
• YP describing achieving 
• YP showing determination 
• YP sharing hopes for the future 
• Parent hopes for their child’s 
future 
• Prof ref to YP goals 
• Prof ref to YP being determined 
• Parent ref to YP helping others 
 
Having adventures and 
fun 
 
• YP ref to enjoyment 
• YP describing having adventures 
• Prof ref to YP having adventures 
Concealing self Other people’s 
assumptions 
• Reflecting on other people’s 
assumptions 
• Parent ref to responses of other’s 
• Ref to lack of flexibility 
 
Time/difficulties fitting it 
all in 
 
• YP ref to time 
• YP describing the challenge of CF 
• Prof ref to logistical challenges 
 
Having to keep 
secrets/concealing self 
 
• Struggling with being different 
• Having to keep secrets 
Unheard voices • Unheard voices 
Wider context Unique individuals 
 
• YP explaining it’s all about the 
individual 
• Ref to individual differences 
 
Interaction with 
developmental stuff: 
changing emotional, 
physical, cognitive 
(maturation) 
 
• Ref change over time – 
responsibility 
• Ref to change – getting older 
• Prof reflection on interaction with 
developmental norms 
Constantly changing 
landscape of CF 
 
• YP reflecting on change over time 
in own CF 
• Prof reflecting on change over time 
in disease 
• Ref to changing landscape of CF 
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Appendix Z. Abridged Research Diary 
March 2017 
Visited the children’s hospital cystic fibrosis (CF) team. They were really encouraging and 
I’m feeling all fired up and excited about the project. They highlighted transitions (e.g. 
between primary and secondary schools) as a particularly challenging time for children and 
young people (CYP) with CF, their families and the medical team. I’ll amend my interview 
schedule accordingly. 
June 2017 
I’ve been reflecting on my choice of methodology. I chose to do a qualitative project despite 
my research background being very strongly quantitative because I find qualitative research 
interesting to read and useful clinically, and I knew if I didn’t do qualitative research during 
training I never would. Trying to get into the qualitative mindset is proving a real challenge – 
it’s such a different way of approaching things. I’ve been trying to get my head around an 
introductory grounded theory text and I’m beginning to wonder if my choice of research 
design was brave or daft!  
August 2017 
I’ve been reflecting on my choice of topic and client group. I felt a lot of pressure to choose a 
topic very early on in training during a time when I was pre-occupied with getting to grips 
with clinical work and navigating the academic demands of training. I think I fell into 
choosing a topic that was familiar both professionally (I’d worked as an assistant 
psychologist in paediatrics prior to training) and personally (I have my own experiences of 
empowerment/disempowerment having grown up with long term health conditions). I’m 
passionate about the topic but it turns out that empowerment is a really complex concept and 
sometimes I wonder if the research process would be easier if I’d chosen a topic less close to 
home. 
March 2018 
I attended the REC meeting today, it’s taken a lot longer than I’d hoped to get to this point 
and I got a real grilling from the committee (15 panel members!). I don’t think they really 
understood qualitative research or CF as they asked me lots of questions about how I was 
going to achieve a representative sample and suggested that I run in person focus groups with 
children with CF (big infection control no no!) 
June 2018 
My project has finally got ethics approval. Now to get R&D approvals for my two Trusts. 
July 2018 
I’ve been trying to find a question for my literature review for what feels like months! I feel 
conflicted about doing a literature review prior to my grounded theory study as this is not in 
keeping with the method. 
August 2018 
I’ve finally heard back from one of the R&D departments. They want me to do some training 
that is only really appropriate for large drug trials! I’m getting frustrated (and a bit panicked) 
about all the hoops! 
October 2018 
Recruitment is so slow, I’m really worried. Have submitted an amendment to enable 
recruitment from CF charities and social media. 
Early December 2018 
Recruitment has continued to be really slow and I’ve found approaching potential participants 
much harder than I expected. I have my first interviews booked in for later this month 
Late December 2018 
Diaster!! I had 3 interviews booked in but ended up ill in hospital myself. I really hope that 
the participants will be understanding and that we can re-book. 
January 2019 
I’ve just done my first interview and I’m buzzing – the YP I spoke to was so reflective and 
insightful, lots of really rich data. I feel re-invigorated after the gruelling ethics process. 
January 2019 
I’m to figure out how to analyse the data. I’ve read at least 4 books about grounded theory 
and there seem to be lots of ways of doing it and no way of knowing if you’re doing it ‘right’! 
Getting really bogged down in fine details. 
Early February 2019 
Recruitment really picked up, I’ve been a bit inundated! I’m really enjoying the interviews – 
I’ve heard some amazing stories. I feel a lot of pressure with the data analysis – time is 
precious for CYP with CF and their families and clinicians, I want to do a good job for all the 
people who have taken the time to talk with me. 
March 2019 
I have all my data now and am slowly getting there with the initial coding but don’t think I 
can get this done before the deadline. 
April 2019 
I’ve decided to defer – this felt like a really difficult decision but I need to concentrate on my 
clinical work. 
Late September 2019 
I’m now focusing on research full time. I’ve completed the line by line coding and have 
developed axial codes. I’ve been spending a lot of time thinking about what the data is saying 
and how my own experiences might impact on the data analysis – feeling very grateful for 
other trainees and friends that know nothing about empowerment in CF, they have been 
excellent sounding boards!  
October 2019 
I’ve been working on the relationships between my axial categories – the model is beginning 
to take shape. I’m feeling excited about part B again. 
November 2019 
I think this qualitative literature review is probably one of the most academically challenging 
things I’ve ever done.  I think the structure of traditional systematic reviews suits me much 
better! 
December 2019 
Final drive for completion. Exhausted but glad to be handing it in! 
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Appendix CC. Example theoretic memos 
Barriers: 
Is keeping secrets a barrier? or could it be a choice? maybe having to keep secrets is a 
barrier? choosing to keep some things private could be part of taking charge. 
 
Are lack of choice and lack of flexibility the same concept? All participants indicated that 
having choice and input into decisions was important. Some also referred to lack of societal 
flexibility e.g around allowing children with CF to eat what they need to eat in the context of  
'healthy schools' 
 
Not sure how to code participant suggestions for improving medical and/or school systems - 
could this be coded under barriers as it helps explain what some of the sub-category mean? 
For e.g. coding suggestions about making clinical environments more child friendly under 
'adult dominated systems'? I suppose they could also be coded as 'being able to be a child' 
 
Being able to be a child: 
Being able to be a child or being able to be myself? Depends who's perspective this is from - 
some of the young people taking part wouldn't necessarily identify as children even if their 
parents would describe them as such. Does one code need to fit all instances? Need to think 
about the language used. 
 
Is 'being able to be  a child/just getting on with life' the same as 'thriving alongside CF'? I'm 
feeling more confident that 'thriving alongside CF' is the central phenomena as it does seem 
to be the thing that links all of the data. I wonder if 'being able to be a child/just getting on 
with life' is a part or consequence of  'thriving alongside CF' - for example Mum of 11yr old 
F seemed to suggest that her daughter was able to just be a child through escapism (although 
could that in itself be a way of taking charge?!). 
 
Taking charge: 
 
Are being in charge and taking charge different concepts? The YP often refer to situations 
where they have actively taken charge rather than someone else putting them in charge.  
 
Adults (professionals and parents?) more likely to refer to external circumstances (e.g. 
starting secondary school) that lead to the YP being in charge. 
 
Is 'holding it all together' what happens when a YP has taken charge? or is that a separate 
code? 
 
How does taking charge relate to changes in responsibility? The professionals tend to see 
taking charge as having complete responsibility but interviews with YP suggest that sharing 
responsibility can be a way of taking charge in a way that enables them to fit in their non-CF 
priorities. 
 
I initial thought of preparing for the future as part of taking charge but now think it might be 
more of a consequence of thriving alongside CF. 
Appendix DD. Feedback form for ethics panel and R&D departments  
Study feedback summary  
Name: Naomi Fairweather 
Study: ‘Thriving alongside CF’: Developing A Grounded Theory of Empowerment in Children 
& Young People with Cystic Fibrosis During Key Life Transitions 
REC reference: 18/LO/0450 
Whilst the importance of patient empowerment is increasingly being recognised, little is 
known about empowerment in children and young people (CYP) with long term conditions. 
Empowerment may be particularly important in CYP with cystic fibrosis (CF) due to high 
treatment burden and limited opportunities for peer support. 
This study employed a Grounded Theory Method to develop a preliminary theory of 
empowerment in CYP with CF.  
Ethical practice was guided by the BPS code of human research ethics (The British 
Psychological Society [BPS], 2014) and the BPS code of ethics and conduct (BPS, 2018). 
Approvals were granted by the REC, HRA and relevant R&D departments.  
Participants were recruited from two NHS Trusts. Informed consent was obtained for all 
participants, with those under 16 years providing assessment. Seven young people with CF, 
four parents and four professionals were interviewed. All participants were fully debriefed, 
no participants reported being distressed by the research.  
Interviews were audio recorded and professionally transcribed (a confidentiality agreement 
was signed), data were analysed using Grounded Theory. 
The emerging model suggests that ‘thriving alongside CF’ may be supported by interactions 
between ‘having a team’ and ‘taking charge and having a voice’, leading to ‘being able to just 
be a child/getting on with life’, that ‘concealing self’ may get in the way of ‘thriving 
alongside CF’ and that these processes occur within wider medical and developmental 
contexts.  
Comparisons were made with existing models of patient empowerment which were based on 
research with adults living with a range of long term conditions. Some similarities were 
noted, particularly in relation to facilitators of empowerment. For e.g. having information 
featured as a key facilitator of empowerment in previous models of empowerment and was 
found to enable ‘taking charge and having a voice’ in the current study. The current study 
moved beyond previous models of patient empowerment by incorporating developmental 
perspectives and factors specific to CF such as the impact of rapid medical advances and 
complexities of peer support in the context of strict infection control guidelines.  
Limitations of the current study included relatively small sample size, and lack of respondent 
validation. Clinical and research implications were discussed including, a need for research 
with CYP who are not currently ‘thriving with CF’ and whose voices were not heard in the 
current study, increased focus on CYP’s support networks in clinic consultations and the 
potential for developing virtual peer support interventions. 
Findings of the study are currently being disseminated to all participants and relevant 
stakeholders. 
 
Appendix EE. Feedback to participants 
 
 
Naomi Fairweather 
Trainee Clinical Psychologist 
Salomons Centre for Applied Psychology 
Canterbury Christ Church University 
1 Meadow Road 
Tunbridge Wells 
TN1 2YG 
‘Thriving alongside CF’ - Empowerment in Children & Young People 
with Cystic Fibrosis (CF) During Times of Change 
 
Thank you for participating in my research and helping me to understand what might help 
children and young people living with CF to feel confident and in control of their lives. I am 
going to briefly outline the research, explain how I analysed the interview data and 
summarise the findings. 
Overview of the research 
Previous research had shown that many children and young people with medical conditions 
want to feel confident and in control of their lives, but often face barriers. Empowering 
people with medical conditions might mean they can stay happier and healthier. I wanted to 
know more about the empowerment in children and young people with CF.  
 
I interviewed 7 young people with CF, 5 parents and 4 CF professionals to find out their 
views. I spent a long time going through the interviews in detail and comparing them to each 
other. I was able to work out some key themes from doing this.  
 
 
 
 
 
What research show? 
 
I found that there are things that make it easier for young people to ‘thrive alongside CF’ 
these were: 
• Having a team 
• Taking charge and having a voice 
 
I also found that there were some barriers to ‘thriving alongside CF’ the main one was 
having to keep secrets or hide CF from others. 
 
It was clear that all young people with CF are unique and things that make it easier or 
harder to thrive change over time. 
 
 
Do you want more information about the study? 
Please contact me via email: n.h.fairweather323@canterbury.ac.uk or leave a message for 
me on a 24-hour voicemail phone line at 01227 927070. If you are under 16 please ask 
your parent/guardian to do this for you. 
Appendix FF Demographic form Version 1.0 01.03.18 IRAS Ref Number: 234289  
Participant ID: 
 
Demographics 
You do not need to answer any of these questions if you do not want to. 
Gender 
 Female 
  
 Male 
  
 Other 
Ethnicity  
How do you define your ethnic identity? Tick all that apply 
 White (British, Irish, Traveller, European, other) 
  
 Black (British, African, Caribbean, other) 
  
 Asian (British, Indian, Pakistani, Bangladeshi, Chinese, other) 
 
  
 Mixed ethnicity  
 
  
 Other (please specify) ______________________ 
Disability 
Do you consider yourself to be disabled? Tick all that apply 
 Yes – physical 
  
 Yes – mental 
  
 Yes – sensory 
 
 
  
 Yes – other 
  
 No 
 
Appendix FF Demographic form Version 1.0 01.03.18 IRAS Ref Number: 234289  
Participant ID: 
 
Education 
Are you currently in education? Tick all that apply 
 Yes – at school 
  
 Yes – educated otherwise 
  
 Yes – at college 
  
 Yes – at university 
 
  
 No 
  
 Full time 
  
 Part time 
Who do you live with? 
 Relatives 
  
 Friends 
  
 Alone 
  
 Other (please specify) __________________________ 
 
Staff 
Profession  
 
 
 
 
 
Professional experience with CF in years  
 
Appendix GG. Health data extraction form Version 2.0   14.04.18  
IRAS Ref Number: 234289 Participant ID: 
 
Health Data 
Age of CF diagnosis, if known  
  
Most Recent Lung Function (FEV, %) Score  
  
Most Recent BMI  
  
Pancreatic insufficiency Yes   No  
  
CF-related diabetes Yes   No  
  
PEG Yes   No  
  
Central venous catheter (Port or Hickman) Yes   No  
  
Chronic infections  
  
  
  
  
  
Episodes of IV antibiotics in previous 12 months  
  
Episodes of oral antibiotics in previous 12 months  
  
On transplant list?  Yes   No  
 
Parent/guardian 
Relationship to child/young person  
  
Current age of child/young person  
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